Language selection

Search

Patent 2360585 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2360585
(54) English Title: PROTEASE
(54) French Title: PROTEASE
Status: Dead
Bibliographic Data
(51) International Patent Classification (IPC):
  • C12N 9/64 (2006.01)
  • A61K 38/48 (2006.01)
  • A61K 39/395 (2006.01)
  • A61K 48/00 (2006.01)
  • C07K 16/40 (2006.01)
  • C12N 5/10 (2006.01)
  • C12N 9/50 (2006.01)
  • C12Q 1/37 (2006.01)
  • G01N 33/53 (2006.01)
  • A61K 38/00 (2006.01)
  • C12Q 1/68 (2006.01)
(72) Inventors :
  • HOFMANN, KAY (Germany)
(73) Owners :
  • MEMOREC BIOTEC GMBH (Germany)
(71) Applicants :
  • MEMOREC MEDICAL MOLECULAR RESEARCH COLOGNE STOFFEL GMBH (Germany)
(74) Agent: NORTON ROSE FULBRIGHT CANADA LLP/S.E.N.C.R.L., S.R.L.
(74) Associate agent:
(45) Issued:
(86) PCT Filing Date: 2000-01-19
(87) Open to Public Inspection: 2000-07-27
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/EP2000/000390
(87) International Publication Number: WO2000/043505
(85) National Entry: 2001-07-23

(30) Application Priority Data:
Application No. Country/Territory Date
199 02 550.9 Germany 1999-01-22
199 25 946.1 Germany 1999-06-08
199 29 115.2 Germany 1999-06-24

Abstracts

English Abstract




The invention relates to protease with two aspartate radicals in a
catalytically active structure, a first aspartate radical being in a sequence
X1GX2GD and a second aspartate radical being in a sequence X3X4DX5, X1, X2, X3
and X5 being selected independently of each other from the following: Ala,
Val, Leu, Met and Ile; and X4 being an aromatic amino acid. The sequences
X1GX2GD and X3X4DX5 lie in a transmembrane region.


French Abstract

L'invention concerne une protéase comportant deux restes aspartate dans une structure catalytiquement active, un premier reste aspartate se situant dans un motif X¿1?GX¿2?GD et un deuxième reste aspartate se situant dans un motif X¿3?X¿4?DX¿5?. La protéase selon l'invention est caractérisée en ce que X¿1?, X¿2?, X¿3? et X¿5? pouvent être choisis indépendamment les uns des autres parmi Ala, Val, Leu, Met et Ile, en ce que X¿4? est un acide aminé aromatique et en ce que les motifs X¿1?GX¿2?GD et X¿3?X¿4?DX¿5? se situent dans une région transmembranaire.

Claims

Note: Claims are shown in the official language in which they were submitted.





-6-

CLAIMS:

1. A protease having two aspartate residues in a catalytically active
structure,
wherein a first aspartate residue resides in an X1GX2GD motif and a second
aspartate residue resides in an X3X4DX5 motif, wherein X1, X2, X3 and X5 are
independently selected from Ala, Val, Leu, Met and Ile, and X4 is an aromatic
amino acid, and the motifs X1GX2GD and X3X4DX5 reside in a transmem-
brane region.

2. The protease according to claim 1, characterized by having the sequence
PALX6YX7V, wherein X6 and X7 independently have the same meaning as X1
and preferably are Leu or Ile.

3. The protease according to any of claims 1 to 2, characterized by having one
of the sequences SEQ ID Nos. 1 to 8 and 18, 19.

4. Nucleic acids coding for a protease according to at least one of claims 1
to 3,
preferably having SEQ ID No. 9-17 or 20.

5. Inhibitors, characterized by inhibiting the expression or activity of the
protease according to any of claims 1 to 3.

6. An antibody directed against proteases according to any of claims 1 to 3.

7. A method for the identification of inhibitors, characterized in that the
activity
of the proteases is measured according to any of claims 1 to 3 in the pres-
ence of potential inhibitors.

8. A medicament or diagnostic agent containing a protease according to any of
claims 1 to 3, a nucleic acid according to claim 4, an inhibitor according to
claim 5, and/or an antibody according to claim 6.




-7-

9. Use of the medicament or diagnostic agent according to claim 8 for the
diagnosis or treatment of diseases which are causally related with the cleav-
age of the amyloid precursor protein, especially Alzheimer's disease.

10. Use of the medicament or diagnostic agent according to claim 8 for the
diagnosis or treatment of diseases which are causally related with a dis-
turbed degradation of hydrophobic signal peptides.

11. Use of the medicament or diagnostic agent according to claim 8 for the
diagnosis or treatment of diseases which are causally related with the accu-
mulation of unfolded proteins in the endoplasmic reticulum.

12. Use of the medicament according to claim 8 for influencing the
presentation
of hydrophobic peptides by histocompatibility complex molecules in condi-
tions such as viral infection, cancer or rejection after transplantation.

13. A cell line, characterized by not expressing any protease according to at
least one of claims 1 to 3 and/or not containing any nucleic acid according to
claim 4.


Description

Note: Descriptions are shown in the official language in which they were submitted.




CA 02360585 2001-07-23
SMB
Protease
The present invention relates to a protease, nucleic acids coding for the
protease,
and the related inhibitors, antibodies, medicaments and diagnostic agents.
The present invention provides a protease having two aspartate residues in a
catalytically active structure, wherein a first aspartate residue resides in
an
XiGX2GD motif and a second aspartate residue resides in;.~n X3X4DX5 motif,
wherein X1, X2, X3 and X5 are independently selected from Ala, Val, Leu, Met
and
Ile, and X4 is an aromatic amino acid, and the motifs X1GXZGD and X3X4DX5
reside
in a transmembrane region. For the motifs, the one-letter code of amino acids
has
been used, i.e., D = Asp, G = Gly, etc.
There is a high probability that such proteases are involved in the cleavage
of the
amyloid precursor protein (APP). In one embodiment of the invention, the
protease
according to the invention is the as yet unidentified y-secretase, which is
involved
in the processing of APP into the amyloid peptides referred to as A~i.
A survey of the role of y-secretases in the genesis of Alzheimer's disease is
given
by S.L. Ross et al. in J. of Biol. Chem. 273 (1998), 15309-15312.
Preferred proteases of the present invention additionally have a sequence
PALX6YX,V, wherein X6 and X, independently have the same meaning as X1.
However, it is preferred that X6 and X, are leucine or isoleucine.
In particular, the proteases are proteases from mammals, especially humans.



CA 02360585 2001-07-23
-2-
The proteases according to the invention preferably have catalytically active
aspartate residues in a region which lies within a transmembrane domain. When
the sequence of a protein is known, transmembrane domains can be predicted due
to different models. They are characterized by the fact that hydrophobic amino
acids are predominant in a region which is flanked by regions in which
hydrophilic
amino acids are predominant.
An aspartate in a transmembrane region can be detected, for example, by the
application of the program "GREASE" which is a part of the FASTA 2.0 program
package. For a window width of 17, a hydrophobicity value of at least 80 must
be
calculated for the aspartate using this program. The FASTA program package has
been described in W.R. Pearson and D.J. Lipman, Proc. Natl. Acad. Sci. U.S.A.
85
(1988), 2444-2448. The program GREASE makes use of the Kyte/Doolittle
algorithm, which has been described in J. Kyte and R.F. Doolittle, J. Mol.
Biol. 157
(1982), 105-132.
Particularly preferred proteases of the present invention are referred to as
psl 1-5
(human psl 1-5: SEQ ID Nos. 1 to 4 + 19; murine psl 2-4: SEQ ID Nos. 5-7;
Sacc.
cerevisiae psl 3: SEQ ID No. 8; human psl2L SEQ ID No. 18).
The invention further relates to variants of the proteases according to the
inven-
tion. Variants are proteins which are derived from the proteases according to
the
invention by one or more mutations, insertions and deletions, especially by
conservative substitutions, in particular, forms truncated or extended on the
N or C
terminus.
The invention also relates to nucleic acids coding for the proteases according
to the
invention. Preferred nucleic acids according to the invention are those having
the
SEQ ID Nos. 9 to 17 + 20 (human psl 1-5: SEQ ID Nos. 9 to 12 + 20; murine psl
2-4: SEQ ID Nos. 13-15, Sacc. cerevisiae psl 3: SEQ ID No. 16, human psl2L SEQ
ID No. 17). Complementary nucleic acids are also part of the invention.
The proteases according to the invention are involved in the cleavage of APP
into
Ap and are thus indirectly involved in the genesis of, for example,
Alzheimer's



CA 02360585 2001-07-23
-3-
disease. Therefore, the invention also relates to inhibitors which inhibit the
expression or activity of the proteases. Such inhibitors can be identified in
simple
methods. Appropriate inhibitors can be detected, for example, by measuring the
expression or activity of the proteases in the presence of potential
inhibitors.
Antibodies directed against the aspartate proteases are particularly suitable
for
measuring the expression and are thus also part of the invention.
The aspartate proteases according to the invention are also involved in the
cleavage of other transmembrane proteins, especially of the receptor protein
Notch
and related proteins which play a role in the development of the nervous
system.
The proteolytic cleavage in the interior of membranes is also involved in
other
important processes, e.g.:
- Proteolytic degradation of N-terminal signal peptides after, their cleavage
by
signal peptidase.
- Proteolytic degradation of C-terminal propeptides such as those formed by
the
transamidase-catalyzed cleavage in the posttranslational GPI anchoring of pro-
teins.
- Generation of peptides for the presentation by histocompatibility complex
molecules of types I and II. For soluble proteins, such peptides are predomi-
nantly produced by the proteasome. However, peptides are also formed from
transmembrane regions of proteins which can only be explained by a cleavage
in the interior of the membrane.
- Proteolytic cleavage of the ER stress sensor protein Irel. The endoplasmic
reticulum possesses a mechanism which detects the accumulation of unfolded
or incorrectly folded proteins and sends a signal into the nucleus. This mecha-

nism is referred to as "unfolded protein response" or UPR and results in the
increased formation of proteins which facilitate the folding. In mammals,
there
are two sensor proteins (Irelalpha and Irelbeta) which respond to folding de-
fects and are then proteolytically cleaved within the membrane.



CA 02360585 2001-07-23
-4-
By using the protease according to the invention or its inhibitors, the
mentioned
processes can be influenced therapeutically.
Useful cell lines include those, in particular, which do not express any of
the
proteases or contain any of the nucleic acids according to the invention, and
preferably those which do not contain any homologous proteases or nucleic
acids
either. Preferably, they can be used to test the activity of the proteases
according
to the method described in Example 1 or to establish inhibitors according to
Example 2. Particularly suitable is Saccharomyces cerevisiae. When the corre-
sponding protease or the nucleic acid coding for it (SEQ ID Nos. 8 and 16) is
known, yeast strains which no longer contain this protein or the nucleic acid
can be
produced by known methods. Therefore, they are preferably suitable as an
expression system for the characterization of the aspartate proteases
according to
the invention or for the identification of suitable inhibitors. Therefore, the
invention
also relates to the corresponding cell lines, preferably yeast cell' lines,
and to the
use of the protein of SEQ ID No. 8 as an aspartate protease, and of the
nucleic
acid of SEQ ID No. 16 for the expression of a protease.
The proteases, nucleic acids, inhibitors and antibodies according to the
invention
can be contained in medicaments and diagnostic agents. They are suitable, in
particular, for the treatment and diagnosis of diseases which are causally
related
with the cleavage of the amyloid precursor protein, especially Alzheimer's
disease.
Example i:
y-secretase assay
The putative y-secretases are stably or transiently transfected into cos-7
cells
which additionally stably express SpA4CT (signal peptide fused to ~3A4,
followed by
APP C-terminus). In this system, y-secretase activity can be detected by the
generation of a 4.6 kDa peptide or by the disappearance of the 11 kDa band of
the
complete SpA4CT. When the pathologically relevant y-secretase is present, both
fragments should be detectable in the interior of the cell. In the supernatant
of the
cells, (3A4 can always be found; it is generated by an endogenous y-secretase



CA 02360585 2001-07-23
-5-
activity residing in the plasma membrane, but which does not play a role in
the
pathogenesis of Alzheimer's disease.
The transfected cells are washed three times with cold DMEM and subsequently
harvested on ice with a squeegee. The cells (about 5 x 106 cells) are
collected by
centrifugation and lysed in 1 ml of lysis buffer (150 mM NaCI, 50 mM Tris-HCI,
pH
7.5, 1% NP-40, 1% Triton X-100, 2 mM EDTA). The nuclei are centrifuged off at
11,000 x g. The supernatant is subjected to immunoprecipitation. Thus, 1 ml of
the cell lysate is mixed with 2 pg/ml of W02 immunoglobulin (anti-~3A4
antibody)
and shaken upside down at 4 °C for 0.5 h. Subsequently, 20 pl of
protein G
sepharose suspension (1:1) is added, followed by shaking upside down at 4
°C for
h. The protein G sepharose is successively washed twice with buffers A, B and
C
(A: 150 mM NaCI, 10 mM Tris-HCI, pH 7.5, 0.2% NP-40, 2 mM EDTA; B: 500 mM
NaCI, 10 mM Tris-HCI, pH 7.5, 0.2% NP-40, 2 mM EDTA; C: 10 mM Tris-HCI, pH
7.5), mixed with 20 pl of 3x sample buffer, heated to 95 °C, and the
supernatant is
coated onto a 12% Tris-Tricine gel. After gel-electrophoretic size
fractionation, the
proteins are transferred to a PVDF membrane and subsequently detected with an
anti-~3A4 antibody.
Example 2:
Identification of a y-secretase inhibitor
For the identification of an inhibitor of the pathologically relevant y-
secretase, the
enzyme is co-expressed with SpA4CT in cos-7 cells according to the above
protocol. The cells are suitably contacted with the substance to be examined
(in
the presence or absence of membrane-permeabilizing agents). Subsequently, the
intracellularly formed ~A4 is detected as described above. A reduction of the
quantity of ~3A4 formed permits to conclude the activity of the substance as a
y-
secretase inhibitor.



CA 02360585 2001-07-23
SEQUENZPROTOKOLL
<110> Memorec Stoffel GmbH
<120> Protease
<130> Protease Memorec
<140>
<141>
<150> 19902550.9
<151> 1999-O1-22
<150> 19925946.1
<151> 1999-06-08
<150> 19929115.2
<151> 1999-06-29
<160> 20
<170> PatentIn Ver. 2.1
<210> 1
<211> 592
<212> PRT
<213> Homo sapiens
<400> 1
Met Ala Ala Ala Val Ala Ala Ala Leu Ala Arg Leu Leu Ala Ala Phe
1 5 10 15
Leu Leu Leu Ala Ala Gln Val Ala Cys Glu Tyr Gly Met Val His Val
20 25 30
Val Ser Gln Ala Gly Gly Pro Glu Gly Lys Asp Tyr Cys Ile Leu Tyr
35 40 45
f
Asn Pro Gln Trp Ala His Leu Pro His Asp Leu Ser Lys Ala Ser Phe
50 55 60
Leu Gln Leu Arg Asn Trp Thr Ala Ser Leu Leu Cys Ser Ala Ala Asp
65 70 75 80
Leu Pro Ala Arg Gly Phe Ser Asn Gln Ile Pro Leu Val Ala Arg Gly
85 90 95
Asn Cys Thr Phe Tyr Glu Lys Val Arg Leu Ala Gln Gly Ser Gly Ala
100 105 110
Arg Gly Leu Leu Ile Val Ser Arg Glu Arg Leu Val Pro Pro Gly Gly
115 120 125
Asn Lys Thr Gln Tyr Asp Glu Ile Gly Ile Pro Val Ala Leu Leu Ser
130 135 190



CA 02360585 2001-07-23
- 2 -
Tyr LysAsp Asp ArgPhe
Met Ile Gly
Leu Phe Arg
Thr Thr
Val
Arg


145 150 155 160


Ala AlaLeu TyrAlaPro LysGlu ValLeuAsp MetVal
Pro Tyr
Asn


165 170 175


Ile IlePhe IleMetAla ValGlyThr ValAlaIleGly TyrTrp
Gly


180 185 190


Ala GlySer ArgAspVal LysLysArg TyrMetLysHis LysArgAsp


195 200 205


Asp GlyPro GluLysGln GluAspGlu AlaValAspVal ThrProVal


210 215 2.20


Met ThrCys ValPheVal ValMetCys CysSerMetLeu ValLeuLeu


225 230 235 240


f.,w', Tyr TyrPhe TyrAspLeu LeuValTyr ValValle Gly IlePheCys
I


245 250 255


Leu AlaSer AlaThrGly LeuTyrSer CysLeuAlaPro CysValArg


260 265 2
70


Arg LeuPro PheGlyLys CysArgIle ProAsnAsnSer LeuProTyr


275 280 285


Phe HisLys ArgProGln AlaArgMet LeuLeuLeuAla LeuPheCys


290 295 300


Val AlaVal SerValVal TrpGlyVal PheArgAsnGlu AspGlnTrp


305 310 315 320


Ala TrpVal LeuGlnAsp AlaLeuGly IleAlaPheCys LeuTyrMet


325 330 335


Leu LysThr IleArgLeu ProThrPhe Lys CysThr LeuLeuLeu
Ala


.:. .
340 345 350


Leu Val Leu PheLeuTyr IlePhe Phe PheIle ThrProPhe
Asp Val


355 360 365


Leu Thr Lys Ser Gly Ser Ser Ile Met Val Glu Val Ala Thr Gly Pro
370 375 380
Ser Asp Ser~Ala Thr Arg Glu Lys Leu Pro Met Val Leu Lys Val Pro
385 390 395 400
Arg Leu Asn Ser Ser Pro Leu Ala Leu Cys Asp Arg Pro Phe Ser Leu
405 410 415
Leu Gly Phe Gly Asp Ile Leu Val Pro Gly Leu Leu Val Ala Tyr Cys
420 425 430
His Arg Phe Asp Ile Gln Val Gln Ser Ser Arg Val Tyr Phe Val Ala
435 440 445



CA 02360585 2001-07-23
- 3 -
CysThrIle AlaTyrGly ValGlyLeu LeuValThr PheValAla Leu


950 455 960


AlaLeuMet GlnArgGly GlnProAla LeuLeuTyr LeuValPro Cys


465 470 475 480


ThrLeuVal ThrSerCys AlaValAla LeuTrpArg ArgGluLeu Gly


485 490 495


ValPheTrp ThrGlySer GlyPheAla LysValLeu ProProSer Pro


500 505 510


TrpAlaPro AlaProAla AspGlyPro GlnProPro LysAspSer Ala


515 520 525


ThrProLeu SerProGln ProProSer GluGluPro AlaThrSer Pro


530 535 590


Trp Pro Ala Glu Gln Ser Pro Lys Ser Arg Thr Ser Glu Glu Met Gly
545 550 555 560
Ala Gly Ala Pro Met Arg Glu Pro Gly Ser Pro Ala Glu Ser Glu Gly
565 570 575
Arg Asp Gln Ala Gln Pro Ser Pro Val Thr Gln Pro Gly Ala Sex Ala
580 585 590
<210> 2
<211> 520
<212> PRT
<213> Homo sapiens
<400> 2
Met Gly Pro Gln Arg Arg Leu Ser Pro Ala Gly Ala Ala Leu Leu Trp
1 5 10 15
Gly Phe Leu Leu Gln Leu Thr Ala Ala Gln Glu Ala Ile Leu His Ala
20 25 30
SerGly GlyThrThr LysAspTyr CysMetLeu TyrAsnPro Tyr
Asn


35 40 45


TrpThrAla LeuProSer ThrLeuGlu AsnAlaThr SerI1eSer Leu


50 55 60


MetAsnLeu ThrSerThr ProLeuCys AsnLeuSer AspIlePro Pro


65 70 75 80


ValGlyIle LysSerLys AlaValVal ValProTrp GlySerCys His


85 90 95


PheLeuGlu LysAlaArg IleAlaGln LysGlyGly AlaGluAla Met


100 105 110


LeuValVal AsnAsnSer ValLeuPhe ProProSer GlyAsnArg Ser


115 120 125





' CA 02360585 2001-07-23
- 4 -
Glu PheProAsp ValLys IleLeuIle AlaPheIle SerTyrLysAsp


130 135 140


Phe ArgAspMet AsnGln ThrLeuGly AspAsnIle ThrValLysMet


145 150 155 160


Tyr SerProSer TrpPro AsnPheAsp TyrThrMet ValValIlePhe


165 170 175


Val IleAlaVal PheThr ValAlaLeu GlyGlyTyr TrpSerGlyLeu


180 185 190


Val GluLeuGlu AsnLeu LysAlaVal ThrThrGlu AspArgGluMet


195 200 205


Arg LysLysLys GluGlu TyrLeuThr PheSerPro LeuThrValVal


210 215 220


Ile PheValVal IleCys CysValMet MetValLeu LeuTyrPhePhe


225 230 235 290


Tyr Lys Trp Leu Val Tyr Val Met Ile Ala Ile Phe Cys Ile Ala Ser
245 250 255


Ala MetSerLeu TyrAsnCysLeu AlaAlaLeu IleHisLys I.lePro


260 265 270 ,


Tyr GlyGlnCys ThrIleAlaCys ArgGlyLys AsnMetGlu ValArg


275 280 285


Leu IlePheLeu SerGlyLeuCys IleAlaVal AlaValVal TrpAla


290 295 300


Val PheArgAsn GluAspArgTrp AlaTrpIle LeuGlnAsp IleLeu


305 310 315 320


Gly IleAlaPhe CysLeuAsnLeu IleLysThr LeuLysLeu ProAsn


325 330 335


Phe LysSerCys ValIleLeuLeu GlyLeuLeu LeuLeuTyr AspVal


340 395 350


Phe Phe Val Phe Ile Thr Pro Phe Ile Thr Lys Asn Gly Glu Ser Ile
355 360 365
Met Val Glu Leu Ala Ala Gly Pro Phe Gly Asn Asn Glu Lys Leu Pro
370 375 380
Val Val Ile Arg Val Pro Lys Leu Ile Tyr Phe Ser Val Met Ser Val
385 390 395 900
Cys Leu Met Pro Val Ser Ile Leu Gly Phe Gly Asp Ile Ile Val Pro
905 410 415
Gly Leu Leu Ile Ala Tyr Cys Arg Arg Phe Asp Val Gln Thr Gly Ser
920 425 430



CA 02360585 2001-07-23
- 5 -
Ser Tyr Ile TyrTyr ValSerSer Thr Ala AlaIle
Val Tyr Gly
Met


935 440 945


Ile Leu Thr PheVal ValLeuVal Leu LysLys GlyGlnPro
Met Ala


450 455 460


Leu Leu Tyr LeuVal ProCysThr LeuIleThrAla SerValVal Ala


465 970 975 980


Trp Arg Arg LysGlu MetLysLys PheTrpLysGly AsnSerTyr Gln


485 490 495


Met Met Asp HisLeu AspCysAla ThrAsnGluGlu AsnProVal Ile


500 505 510


Ser Gly Glu GlnIle ValGlnGln


515 520


<210> 3


<211> 377


<212> PRT


<213> Homo Sapiens


<400> 3


Met Asp Ser AlaLeu SerAspPro HisAsnGlySer AlaGluAla Gly


1 5 10 15


Gly Pro Thr AsnSer ThrThrArg ProProSerThr ProGluGly Ile


20 25 30


Ala Leu Ala TyrGly SerLeuLeu LeuMetAlaLeu LeuProIle Phe


35 90 95


Phe Gly Ala LeuArg SerValArg AlaArgGly Lys Ala Ser
Cys Asn


50 55 60


Asp Met Pro GluThr IleThrSer AspAlaAla Pro Ile
Arg Arg
Phe


65 70 75 80


Ile Ala Ser Cys Thr Leu Leu Gly Leu Tyr Leu Phe Phe Lys Ile Phe
85 90 95
Ser Gln Glu Tyr Ile Asn Leu Leu Leu Ser Met Tyr Phe Phe Val Leu
100 105 110
Gly Ile Leu Ala Leu Ser His Thr Ile Ser Pro Phe Met Asn Lys Phe
115 120 125
Phe Pro Ala Ser Phe Pro Asn Arg Gln Tyr Gln Leu Leu Phe Thr Gln
130 135 140
Gly Ser Gly Glu Asn Lys Glu Glu Ile Ile Asn Tyr Glu Phe Asp Thr
145 150 155 160
Lys Asp Leu Val Cys Leu Gly Leu Ser Ser Ile Val Gly Val Trp Tyr
165 170 175



CA 02360585 2001-07-23
- 6 -
LeuLeu ArgLysHisTrp IleAlaAsn AsnLeu PheGlyLeu AlaPhe


180 185 190


SerLeu AsnGlyValGlu LeuLeuHis LeuAsn AsnValSer ThrGly


195 200 205


CysIle LeuLeuGlyGly LeuPheIle TyrAsp ValPheTrp ValPhe


210 215 220


GlyThr AsnValMetVal ThrValAla LysSer PheGluAla ProIle


225 230 235 290


LysLeu ValPheProGln AspLeuLeu GluLys GlyLeuGlu AlaAsn


295 250 255


AsnPhe AlaMetLeuGly LeuGlyAsp ValVal IleProGly IlePhe


260 265 270


Ile Ala Leu Leu Leu Arg Phe Asp Ile Ser Leu Lys Lys Asn Thr His
275 280 285


Thr TyrPheTyr ThrSerPheAla AlaTyrIle PheGlyLeu GlyLeu


290 295 300


Thr IlePheIle MetHisIlePhe LysHisAla GlnProAla LeuLeu


305 310 315 ,320


Tyr LeuValPro AlaCysIleGly PheProVal LeuValAla LeuAla


325 330 335


Lys GlyGluVal ThrGluMetPhe SerTyrGlu GluSerAsn ProLys


390 395 350


Asp ProAlaAla ValThrGluSer LysGluGly ThrGluAla SerAla


355 360 365


Ser LysGlyLeu GluLysLysGlu Lys


370 375


<210> 4


<211> 384


<212> PRT


<213> Homosapiens


<400> 4


Met Ala GlnThrTyr SerTrpAla TyrSerLeu ValAspSer Ser
Glu


1 5 10 15


Gln Val ThrPheLeu IleSerIle LeuLeuIle ValTyrGly Ser
Ser


20 25 30


Phe Arg LeuAsnMet AspPheGlu AsnGlnAsp LysG1uLys Asp
Ser


35 40 95


Ser Asn SerSerGly SerPheAsn GlyAsnSer ThrAsnAsn Ser
Ser


50 55 60





CA 02360585 2001-07-23
_ 7 _
Ile Gln Thr Ile Asp Ser Thr Gln Ala Leu Phe Leu Pro Ile Gly Ala
65 70 75 80
Ser Val Ser Leu Leu Val Met Phe Phe Phe Phe Asp Ser Val Gln Val
85 90 95
Val Phe Thr Ile Cys Thr Ala Val Leu Ala Thr Ile Ala Phe Ala Phe
100 105 110
Leu Leu Leu Pro Met Cys Gln Tyr Leu Thr Arg Pro Cys Ser Pro Gln
115 120 125
Asn Lys Ile Ser Phe Gly Cys Cys Gly Arg Phe Thr Ala Ala Glu Leu
130 135 140
Leu Ser Phe Ser Leu Ser Val Met Leu Val Leu Ile Trp Val Leu Thr
195 150 155 160
Gly His Trp Leu Leu Met Asp Ala Leu Ala Met Gly Leu Cys Val Ala
165 170 175
Met Ile Ala Phe Val Arg Leu Pro Ser Leu Lys Val. Ser Cys Leu Leu
180 185 190
Leu Ser Gly Leu Leu Ile Tyr Asp Val Phe Trp Val Phe Phe S.er Ala
195 200 205 ,
Tyr Ile Phe Asn Ser Asn Val Met Val Lys Val Ala Thr Gln Pro Ala
210 215 220
Asp Asn Pro Leu Asp Val Leu Ser Arg Lys Leu His Leu Gly Pro Asn
225 230 235 240
Val Gly Arg Asp Val Pro Arg Leu Ser Leu Pro Gly Lys Leu Val Phe
295 250 255
Pro Ser Ser Thr Gly Ser His Phe Ser Met Leu Gly Ile Gly Asp Ile
260 265 270
Val Met Pro Gly Leu Leu Leu Cys Phe Val Leu Arg Tyr Asp Asn Tyr
275 280 285
Lys Lys Gln Ala Ser Gly Asp Ser Cys Gly Ala Pro Gly Pro Ala Asn
290 295 300
Ile Ser Gly Arg Met Gln Lys Val Ser Tyr Phe His Cys Thr Leu Ile
305 310 315 320
Gly Tyr Phe Val Gly Leu Leu Thr Ala Thr Val Ala Ser Arg Ile His
325 330 335
Arg Ala Ala Gln Pro Ala Leu Leu Tyr Leu Val Pro Phe Thr Leu Leu
340 345 350
Pro Leu Leu Thr Met Ala Tyr Leu Lys Gly Asp Leu Arg Arg Met Trp
355 360 365



CA 02360585 2001-07-23
Ser Glu Pro Phe His Ser Lys Ser Ser Ser Ser Arg Phe Leu Glu Val
370 375 380
<210> 5
<211> 113
<212> PRT
<213> Mus musculus
<400> 5
Val Leu Gly Phe Gly Asp Ile Ile Val Pro Gly Leu Leu Ile Ala Tyr
1 5 10 15
Cys Arg Arg Phe Asp Val Gln Thr Gly Ser Ser Ile Tyr Tyr Ile Ser
20 25 30
Ser Thr Ile Ala Tyr Ala Val Gly Met Ile Ile Thr Phe Val Val Leu
35 90 45
Met Val Met Lys Thr Gly Gln Pro Ala Leu Leu Tyr Leu Val Pro Cys
50 55 60
Thr Leu Ile Thr Val Ser Val Val Ala Trp Ser Arg Lys Glu Met Lys
65 70 75 80
Lys Phe Trp Lys Gly Ser Ser Tyr Gln Val Met Asp His Leu AspITyr
85 90 95
Ser Thr Asn Glu Glu Asn Pro Val Thr Thr Asp Glu Gln Ile Val Gln
100 105 110
Gln
<210> 6
<211> 378
<212> PRT
<213> Mus musculus
<400> 6
Met Asp Ser Ala Val Ser Asp Pro His Asn Gly Ser Ala Glu Ala Gly
1 5 10 15
Thr Pro Ala Asn Gly Thr Thr Arg Pro Pro Ser Thr Pro Glu Gly Ile
20 25 30
Ala Leu Ala Tyr Gly Ser Leu Leu Leu Met Ala Leu Leu Pro Ile Phe
35 90 45
Phe Gly Ala Leu Pro Ser Val Arg Cys Ala Arg Gly Lys Ser Ser Ser
50 55 60
Asp Met Pro Glu Thr Ile Thr Ser Arg Asp Ala Ala Arg Phe Pro Ile
65 70 75 80
Ile Ala Ser Cys Thr Leu Leu Gly Leu Tyr Leu Phe Phe Lys Ile Phe
85 90 95



' CA 02360585 2001-07-23
_ g _
Ser Gln Glu Tyr Ile Asn Leu Leu Leu Ser Met Tyr Phe Phe Val Leu
100 105 110
Gly Ile Leu Ala Leu Ser His Thr Ile Ser Pro Phe Met Asn Lys Phe
115 120 125
Phe Pro Ala Asn Phe Pro Asn Arg Gln Tyr Gln Leu Leu Phe Thr Gln
130 135 140
Gly Ser Gly Glu Asn Lys Glu Glu Ile Ile Asn Tyr Glu Phe Asp Thr
145 150 155 160
Lys Asp Leu Val Cys Leu Gly Leu Ser Ser Val Val Gly Val Trp Tyr
165 170 175
Leu Leu Arg Lys His Trp Ile Ala Asn Asn Leu Phe Gly Leu Ala Phe
180 185 190
Ser Leu Asn Gly Val Glu Leu Leu His Leu Asn Asn Val Ser Thr Gly
195 200 205
Cys Ile Leu Leu Gly Gly Leu Phe Ile Tyr Asp Ile Phe Trp Val Phe
210 215 220
Gly Thr Asn Val Met Val Thr Val Ala Lys Ser Phe Glu Ala Pro Ile
225 230 235 ,290
Lys Leu Val Phe Pro Gln Asp Leu Leu Glu Lys Gly Leu Glu Ala Asp
245 250 255
Asn Phe Ala Met Leu Gly Leu Gly Asp Ile Val Ile Pro Gly Ile Phe
260 265 270
Ile Ala Leu Leu Leu Arg Phe Asp Ile Ser Leu Lys Lys Asn Thr His
275 280 285
Thr Tyr Phe Tyr Thr Ser Phe Ala Ala Tyr Ile Phe Gly Leu Gly Leu
290 295 300
f; ..
Thr Ile Phe Ile Met His Ile Phe Lys His Ala Gln Pro Ala Leu Leu
305 310 315 320
Tyr Leu Val Pro Ala Cys Ile Gly Phe Pro Val Leu Val Ala Leu Ala
325 330 335
Lys Gly Glu Val Ala Glu Met Phe Ser Tyr Glu Glu Ser Asn Pro Lys
340 345 350
Asp Pro Ala Ala Val Thr Glu Ser Lys Glu Glu Ser Thr Glu Ala Ser
355 360 365
Ala Ser Lys Arg Leu Glu Lys Lys Glu Lys
370 375
<210> 7
<211> 257
<212> PRT
<213> Mus musculus



CA 02360585 2001-07-23
- 10 -
<400> 7
Gln Asn Lys Ile Ser Phe Gly Cys Cys Gly Arg Phe Thr Ala Ala Glu
1 5 10 15
Leu Leu Ser Phe Tyr Leu Ser Val Met Leu Val Leu Ile Trp Val Leu
20 25 30
Thr Gly His Trp Leu Leu Met Asp Ala Leu Ala Met Gly Leu Cys Val
35 40 45
Ala Met Ile Ala Phe Val Arg Leu Pro Ser Leu Lys Val Ser Cys Leu
50 55 60
Leu Leu Ser Gly Leu Leu Ile Tyr Asp Val Phe Trp Val Phe Phe Ser
65 70 75 80
Ala Tyr Ile Phe Asn Ser Asn Val Met Val Lys Val Ala Thr Gln Pro
85 90 95
Ala Asp Asn Pro Leu Asp Val Leu Ser Arg Lys Leu His Leu Gly Pro
100 105 110
Asn Val Gly Arg Asp Val Pro Arg Leu Ser Leu Pro Gly Lys Leu Val
115 120 125
Phe Pro Ser Ser Thr Gly Ser His Phe Ser Met Leu Gly Tle Gly~Asp
130 135 140
Ile Val Met Pro Gly Leu Leu Leu Cys Phe Val Leu Arg Tyr Asp Asn
195 150 155 160
Tyr Lys Lys Gln Ala Ser Gly Asp Ser Cys Gly Ala Pro Gly Xaa Ala
165 170 175
Asn Ile Ser Gly Arg Met Gln Lys Val Ser Tyr Phe His Cys Thr Leu
180 185 190
Ile Gly Tyr Phe Val Gly Leu Leu Thr Ala Thr Val Ala Ser Arg Val
195 200 205
His Arg Ala Ala Gln Pro Ala Leu Leu Tyr Leu Val Pro Phe Thr Leu
210 215 220
Leu Pro Leu Leu Thr Met Ala Tyr Leu Lys Gly Asp Leu Arg Arg Met
225 230 235 290
Trp Ser Glu Pro Phe His Ser Lys Ser Ser Ser Ser Arg Phe Leu Glu
245 250 255
Val
<210> 8
<211> 587
<212> PRT
<213> Saccharomyces cerevisiae
<210> 7
<211> 257
<212> PRT
<213> Mus mu


w
' CA 02360585 2001-07-23
- 11 -
<400> 8
Met Asp Lys Tyr Leu Asn Ser Phe Val Asp His Leu Ser Glu Trp Ser
1 5 10 15
Ser Arg Ala Phe Arg Asn Asn Ser Ser Ser Ala Asn Gln Ser Ala Ser
20 25 30
Asn Lys Glu Leu Glu Gln Val Phe Glu Gln Ile Asn Ala Ile Val Glu
35 40 q5
Asn His Asn Asn Lys Leu Thr Thr Ala Phe Asp Lys Ile Ser Tyr Arg
50 55 60
Val Ala His Lys Ile Thr His Leu Val Glu Ser His Ser Leu Val Phe
65 70 75 80
Asn Tyr Ala Thr Leu Val Leu Ile Ala Ser Ala Leu Val Val Ile Gly
85 90 95
Ser Phe Thr Ser Ile Ser Ser Ile Pro Phe Thr Ala Leu Pro Pro Thr
100 105 110
Arg Glu His Ser Leu Phe Asp Pro Thr Asp Phe Asp Val Asp His Asp
115 120 125
Cys His Val Ile Tyr Arg Glu Asn Asp Glu Asp Lys Lys Lys Lys,Lys
130 135 190
Lys Ser Lys Arg Phe Phe Asp Met Met Asp Glu Lys His Ala Ile Ile
145 150 155 160
Leu Pro Leu Thr Ser Gly Cys Thr Leu Leu Ala Leu Tyr Phe Val Ile
165 170 175
Lys Lys Leu His Leu Asn Trp Leu Lys Tyr Val Val Lys Ile Leu Asn
180 185 190
Phe Asn Ile Thr Leu Leu Asn Ile Pro Ala Gly Thr Phe Val Tyr Ser
;, ; 195 200 205
Tyr Phe Leu Asn Ser Leu Phe Arg Asn Leu Ser His Leu Ala Ser Trp
210 215 220
Asn Pro Leu Val Val Leu Pro Arg Tyr Arg Val Thr Ile Ala Asp Asp
225 230 235 240
Asn Glu Asp Leu Asn Lys Ile Gly Gly Phe Val Thr Asn Leu Asn Tyr
295 250 255
Lys Asp Gly Leu Thr Asn Ser Val Val His Lys Lys Thr Leu Asp Glu
260 265 270
Ile Glu Lys Asp His Trp Met Lys His Phe Tyr Arg Arg Glu Leu Val
275 280 285
Glu Pro Lys Asp Ile Lys Ser Lys Arg Gln Ile Ser Asn Met Tyr Leu
290 295 300



CA 02360585 2001-07-23
- 12 -
Asn Ser Ala Leu Ile Val Ser Phe Val Leu Ser Ile Val Ser Thr Val
305 310 315 320
Tyr Phe Tyr Leu Ser Pro Asn Asp Trp Leu Ile Ser Asn Ala Val Ser
325 330 335
Met Asn Met Ala Ile Trp Ser Ile Ala Gln Leu Lys Leu Lys Asn Leu
340 395 350
Lys Ser Gly Ala Leu Ile Leu Ile Ala Leu Phe Phe Tyr Asp Ile Cys
355 360 365
Phe Val Phe Gly Thr Asp Val Met Val Thr Val Ala Thr Asn Leu Asp
370 375 380
Ile Pro Val Lys Leu Ser Leu Pro Val Lys Phe Asn Thr Ala Gln Asn
385 390 395 400
r'"<%y; Asn Phe Asn Phe Ser Ile Leu Gly Leu Gly Asp Ile Ala Leu Pro Gly
405 910 415
Met Phe Ile Ala Met Cys Tyr Lys Tyr Asp Ile Trp Lys Trp His Leu
420 425 430
Asp His Asp Asp Thr Glu Phe His Phe Leu Asn Trp Ser Tyr Val Gly
435 490 445
Lys Tyr Phe Ile Thr Ala Met Val Ser Tyr Val Ala Ser Leu Val Ser
450 455 460
Ala Met Val Ser Leu Ser Ile Phe Asn Thr Ala Gln Pro Ala Leu Leu
465 470 475 480
Tyr Ile Val Pro Ser Leu Leu Ile Ser Thr Ile Leu Val Ala Cys Trp
485 490 495
Asn Lys Asp Phe Lys Gln Phe Trp Asn Phe Gln Tyr Asp Thr Ile Glu
500 505 510
r.
a,
Val Asp Lys Ser Leu Lys Lys Ala Ile Glu Lys Lys Glu Asn Ser Ile
515 520 525
Thr Tyr Ser Thr Phe Ile Leu Ser Glu Tyr Tyr Asn Asp Ala Asp Lys
530 535 540
Tyr Ala Leu Leu Gly Asp Asp Val Asn Glu Asn Phe Asp Asp Asp Glu
545 550 555 560
Glu Phe Val Gln Glu Glu Asp Leu Ser Asp Ser Ser Glu Glu.Glu Leu
565 570 575
Ser Glu Glu Asp Leu Leu Asp Asp Glu Ser Ser
580 585
<210> 9
<211> 1776
<212> DNA



CA 02360585 2001-07-23
- 13 -
<213> Saccharomyces cerevisiae
<400> 9
atggcggcag cggtggcggc tgcgctggcg cggcttttgg cggcctttct gctcctcgcg 60
gcccaggtgg cctgtgagta cggcatggtg cacgtggtct cccaggccgg gggccccgaa 120
ggcaaagact actgcatcct ctacaacccg cagtgggccc atcttccgca cgacctcagc 180
aaggcatctt tcctgcagct gcgcaactgg acggcctccc tgctctgctc cgcagccgac 240
ctccccgccc gtggcttcag caaccagatc ccgctggtgg cgcgggggaa ctgcaccttc 300
tatgagaaag tgaggctggc ccagggcagc ggagcacgcg ggctgctcat cgtcagcagg 360
gagaggctgg tccccccggg gggtaataag acgcagtatg atgagattgg cattcccgtg 420
gccctgctca gctacaaaga catgctggac atcttcacgc gtttcggccg cacggtgagg 480
gcggcgctgt atgcgcctaa ggagccggtg ctggactaca acatggtcat catcttcatc 540
atggctgtgg gcaccgtcgc catcggcggc tactgggccg ggagtcggga cgtgaagaaa 600
aggtacatga agcacaagcg cgacgatggg cccgagaagc aggaggacga ggcggtggac 660
gtgacgccgg tgatgacctg cgtgtttgtg gtgatgtgct gctccatgct ggtgctgctc 720
tactacttct acgacctcct cgtgtacgtg gtcatcggga tcttctgcct ggcctccgcc 780
accggcctct acagctgcct ggcgccctgt gtgcggcggc tgcccttcgg caagtgcagg 840
atccccaaca acagcctgcc ctacttccac aagcgcccgc aggcccgtat gctgctcctg 900
gcgctcttct gcgtggccgt cagcgtggtg tggggcgtct tccgcaacga ggaccagtgg 960
gcctgggtcc tccaggatgc cctgggcatc gccttctgcc tctacatgct gaagaccatc 1020
cgtctgccca ccttcaaggc ctgcacgctg ctgctgctgg tgctgttcct ctacgacatc 1080
ttcttcgtgt tcatcacgcc cttcctgacc aagagtggga gcagcatcat ggtggaggtg 1140
gccactgggc cctcggactc agccacccgt gagaagctgc ccatggtcct gaaggtgccc 1200
aggctgaact cctcacctct ggccctgtgt gaccggccct tctccctcct gggtttcgga 1260
gacattttgg tgccagggct gctggtggcc tactgccaca ggtttgacat ccaggtacag 1320
tcctccaggg tatacttcgt ggcctgcacc atcgcctatg gcgttggcct ccttgtgaca 1380
ttcgtggcac tggccctgat gcagcgtggc cagcccgctc tcctctacct ggtgccctgc 1440
acgctggtga cgagctgcgc tgtggcgctc tggcgccggg agctgggcgt gttctggacg 1500
ggcagcggct ttgcgaaagt cctacctcca tctccgtggg ccccagcacc agccgacggc 1560
ccgcagcctc ccaaagactc tgccacgcca ctctccccgc agccgcccag cgaagaacca 1620
gccacatccc cctggcctgc tgagcagtcc ccaaaatcac gcacgtccga ggagatgggg 1680
gctggagccc ccatgcggga gcctgggagc ccagctgaat ccgagggccg ggaccaggcc 1790
cagccgtccc cggtaaccca gcctggcgcc tcggcc 1776
<210> 10
<211> 1560
<212> DNA
<213> Homo sapiens
<900> 10
atggggccgc agcggcggct gtcccctgcc ggggccgccc tactctgggg cttcctgctc 60
cagctgacag ccgctcagga agcaatcttg catgcgtctg gaaatggcac aaccaaggac 120
tactgcatgc tttataaccc ttattggaca gctcttccaa gtaccctaga aaatgcaact 180
tccattagtt tgatgaatct gacttccaca ccactatgca acctttctga tattcctcct 240
gttggcataa agagcaaagc agttgtggtt ccatggggaa gctgccattt tcttgaaaaa 300
gccagaattg cacagaaagg aggtgctgaa gcaatgttag ttgtcaataa~cagtgtccta 360
tttcctccct caggtaacag atctgaattt cctgatgtga aaatactgat tgcatttata 420
agctacaaag actttagaga tatgaaccag actctaggag ataacattac tgtgaaaatg 480
tattctccat cgtggcctaa ctttgattat actatggtgg ttatttttgt aattgcggtg 540
ttcactgtgg cattaggtgg atactggagt ggactagttg aattggaaaa cttgaaagca 600
gtgacaactg aagatagaga aatgaggaaa aagaaggaag aatatttaac ttttagtcct 660
cttacagttg taatatttgt ggtcatctgc tgtgttatga tggtcttact ttatttcttc 720
tacaaatggt tggtttatgt tatgatagca attttctgca tagcatcagc aatgagtctg 780
tacaactgtc ttgctgcact aattcataag ataccatatg gacaatgcac gattgcatgt 890
cgtggcaaaa acatggaagt gagacttatt tttctctctg gactgtgcat agcagtagct 900
gttgtttggg ctgtgtttcg aaatgaagac aggtgggctt ggattttaca ggatatcttg 960
gggattgctt tctgtctgaa tttaattaaa acactgaagt tgcccaactt caagtcatgt 1020



CA 02360585 2001-07-23
- 14 -
gtgatacttc taggccttct cctcctctat gatgtatttt ttgttttcat aacaccattc 1080
atcacaaaga atggtgagag tatcatggtt gaactcgcag ctggaccttt tggaaataat 1140
gaaaagttgc cagtagtcat cagagtacca aaactgatct atttctcagt aatgagtgtg 1200
tgcctcatgc ctgtttcaat attgggtttt ggagacatta ttgtaccagg cctgttgatt 1260
gcatactgta gaagatttga tgttcagact ggttcttctt acatatacta tgtttcgtct 1320
acagttgcct atgctattgg catgatactt acatttgttg ttctggtgct gatgaaaaag 1380
gggcaacctg ctctcctcta tttagtacct tgcacactta ttactgcctc agttgttgcc 1440
tggagacgta aggaaatgaa aaagttctgg aaaggtaaca gctatcagat gatggaccat 1500
ttggattgtg caacaaatga agaaaaccct gtgatatctg gtgaacagat tgtccagcaa 1560
<210> 11
<211> 1131
<212> DNA
<213> Homo sapiens
<900> 11
atggactcgg ccctcagcga tccgcataac ggcagtgccg aggcaggcgg ccccaccaac 60
agcactacgc ggccgccttc cacgcccgag ggcatcgcgc tggcctacgg cagcctcctg 120
ctcatggcgc tgctgcccat cttcttcggc gccctgcgct ccgtacgctg cgcccgcggc 180
aagaatgctt cagacatgcc tgaaacaatc.accagccggg atgccgcccg cttccccatc 240
atcgccagct gcacactctt ggggctctac ctctttttca aaatattctc ccaggagtac 300
atcaacctcc tgctgtccat gtatttcttc gtgctgggaa tcctggccct gtcccacacc 360
atcagcccct tcatgaataa gttttttcca gccagctttc caaatcgaca gtaccagctg 420
ctcttcacac agggttctgg ggaaaacaag gaagagatca tcaattatga atttgacacc 480
aaggacctgg tgtgcctggg cctgagcagc atcgttggcg tctggtacct gctgaggaag 540
cactggattg ccaacaacct ttttggcctg gccttctccc ttaatggagt agagctcctg 600
cacctcaaca atgtcagcac tggctgcatc ctgctgggcg gactcttcat ctacgatgtc 660
ttctgggtat ttggcaccaa tgtgatggtg acagtggcca agtccttcga ggcaccaata 720
aaattggtgt ttccccagga tctgctggag aaaggcctcg aagcaaacaa ctttgccatg 780
ctgggacttg gagatgtcgt cattccaggg atcttcattg ccttgctgct gcgctttgac 840
atcagcttga agaagaatac ccacacctac ttctacacca gctttgcagc ctacatcttc 900
ggcctgggcc ttaccatctt catcatgcac atcttcaagc atgctcagcc tgccctccta 960
tacctggtcc ccgcctgcat cggttttcct gtcctggtgg cgctggccaa gggagaagtg 1020
acagagatgt tcagttatga ggagtcaaat cctaaggatc cagcggcagt.gacagaatcc 1080
aaagagggaa~cagaggcatc agcatcgaag gggctggaga agaaagagaa a 1131
;~ ~; <210> 12
<211> 1152
<212> DNA
<213> Homo Sapiens
<400> 12
atggcggagc agacctactc gtgggcctat tccctggtgg attccagtca agtgtctaca 60
tttctgattt ccattcttct tatagtctat ggtagtttca ggtcccttaa tatggacttt 120
gaaaatcaag ataaggagaa agacagtaat agttcttctg ggtctttcaa tggcaacagc 180
accaataata gcatccaaac aattgactct acccaggctc tgttccttcc aattggagca 240
tctgtctctc ttttagtaat gttcttcttc tttgactcag ttcaagtagt ttttacaata 300
tgtacagcag ttcttgcaac gatagctttt gcttttcttc tcctcccgat gtgccagtat 360
ttaacaagac cctgctcacc tcagaacaag atttcctttg gttgctgtgg acgtttcact 420
gctgctgagt tgctgtcatt ctctctgtct gtcatgctcg tcctcatctg ggttctcact 480
ggccattggc ttctcatgga tgcactggcc atgggcctct gtgtcgccat gatcgccttt 540
gtccgcctgc cgagcctcaa ggtctcctgc ctgcttctct cagggcttct catctatgat 600
gtcttttggg tatttttctc agcctacatc ttcaatagca acgtcatggt gaaggtggcc 660
actcagccgg ctgacaatcc ccttgacgtt ctatcccgga agctccacct ggggcccaat 720
gttgggcgtg atgttcctcg cctgtctctg cctggaaaac tggtcttccc aagctccact 780
ggcagccact tctccatgtt gggcatcgga gacatcgtta tgcctggtct cctactatgc 840



CA 02360585 2001-07-23
- 15 -
tttgtccttc gctatgacaa ctacaaaaag caagccagtg gggactcctg tggggcccct 900
ggacctgcca acatctccgg gcgcatgcag aaggtctcct actttcactg caccctcatc 960
ggatactttg taggcctgct cactgctact gtggcgtctc gcattcaccg ggccgcccag 1020
cccgcccttc tctatttggt gccatttact ttattgccac tcctcacgat ggcctattta 1080
aagggcgacc tccggcggat gtggtctgag cctttccact ccaagtccag cagctcccga 1190
ttcctggaag to 1152
<210> 13
<211> 339
<212> DNA
<213> Mus musculus
<400> 13
gtattgggtt tcggagatat cattgtacca ggcctgttga ttgcatattg tagaagattc 60
gatgttcaga ctggttcttc tatatactat atttcatcca caattgccta tgctgttggc 120
atgatcatta cctttgttgt cctgatggtg atgaaaacag ggcagcctgc tctcctctac 180
ttggtacctt gtacacttat tactgtctca gtcgttgctt ggagtcgtaa ggaaatgaaa 240
aagttctgga aaggcagcag ctatcaggtg atggaccacc tggactattc aacaaatgaa 300
gaaaatccag tgacgactga tgagcagatt gtacaacag 339
<210> 14
<211> 1134
<212> DNA
<213> Mus musculus
<400> 14
atggattcgg ctgtcagcga tccgcacaac ggcagcgccg aggctggcac cccagccaac 60
ggcacgacgc ggccgccctc cacgcccgag ggcatcgcgc tggcctacgg cagcctcctg 120
ctcatggcgc tgctgcccat cttcttcggc gccctgccgt cggtgcgctg cgcccgcggc 180
aagagctctt cggacatgcc agaaaccatc accagtcgag atgccgcccg cttccccatc 240
atcgccagct gcacactcct ggggctctac ctctttttca aaatattctc ccaggagtac 300
atcaacctct tgctgtccat gtatttcttc gtgctgggga tcctggccct gtcacacacc 360
atcagcccct tcatgaataa gttttttcca gccaacttcc caaaccgcca gtatcagctg 420
ctcttcacac agggctctgg ggaaaacaaa gaagagatca tcaactatga gtttgacact 480
aaggacctgg tgtgcctggg cctaagcagc gtcgttggtg tctggtacct tctgaggaag 540
cactggattg ccaacaacct gtttggcctg gccttctccc ttaatggggt agagctcctg 600
cacctgaaca acgtgagcac tggctgtatc ctgctcggag gactcttcat ctatgacatc 660
ttctgggtat tcggcaccaa cgtgatggtg acagtggcca agtcctttga ggcaccaata 720
aaattggtgt tcccccagga tctgctggag aagggccttg aagcagacaa ctttgccatg 780
ctgggacttg gagacattgt cattccaggg atcttcattg ccttactgct tcgttttgac 840
atcagcttga agaagaacac gcacacctac ttctacacca gcttcgccgc ctacatcttc 900
ggcctgggtc tcaccatctt catcatgcac atcttcaagc acgcccagcc ggctctcctg 960
tacctggtcc ctgcctgcat cggctttcct gtcctggtgg cactagccaa gggagaagtg 1020
gccgagatgt tcagttatga ggagtccaac cctaaagatc cagcagccgt gactgaatcc 1080
aaagaggagt caacagaggc gtcggcatcg aagaggctag agaagaagga gaaa 1134
<210> 15
<211> 771
<212> DNA
<213> Mus musculus
<400> 15
cagaacaaga tttccttcgg ttgctgtggg cgtttcactg ctgccgagct gctgtcgttc 60
tacctgtctg tcatgctcgt cctcatctgg gttctcactg gccactggct tctcatggat 120
gctctggcca tgggtctctg tgttgccatg atcgccttcg tccgcctgcc aagcctcaag 180



CA 02360585 2001-07-23
- 16 -
gtttcctgcc tgcttctctc agggcttctc atctacgatg tcttctgggt gttcttctca 240
gcctacatct tcaacagtaa tgtcatggtg aaagtggcca cacagccagc tgacaatccc 300
ctcgacgttc tgtccaggaa gctccacctg ggacccaatg tggggcgtga tgttcctcgc 360
ctgtctttgc ctggaaaatt ggtcttccca agctccactg gcagtcactt ctctatgctg 420
ggcatcgggg acattgtgat gcccggcctc ctgttatgct ttgttcttcg ctatgacaac 980
tacaagaaac aagccagtgg tgactcgtgt ggggcccctg gcanngccaa tatctctggg 540
cgcatgcaga aggtctccta cttccactgc accctcatcg ggtactttgt aggtctgctc 600
actgcgactg tggcgtctcg cgtccaccga gctgcccagc cagctctcct ctacttggtg 660
ccatttaccc tattgccact cctcaccatg gcctacctaa agggtgactt acggaggatg 720
tggtctgagc ccttccactc caagtccagc agctcccggt tcctggaagt a 771
<210> 16
<211> 1761
<212> DNA
<213> Saccharomyces cerevisiae
<400> 16
atggacaagt atttgaattc atttgttgac cacctttcag agtggtcatc tcgtgccttt 60
aggaacaatt catcaagcgc taaccaaagt gcgtcgaaca aggaattaga acaagttttt 120
gaacagatca atgctatagt tgaaaaccac aataacaaat taaccactgc ctttgataag 180
atatcatatc gcgttgctca caagattaca cacttggtgg aaagccattc tttagtattc 240
aactacgcca ctttagttct catcgcaagt gctttggtcg ttattggctc atttacgtct 300
atttcttcta ttccatttac agctctacct cctacgagag aacactcatt gtttgatcct 360
acagattttg atgtggacca cgactgtcat gttatctacc gcgagaatga cgaagataaa 420
aagaaaaaga agaaaagcaa gaggtttttc gatatgatgg atgaaaaaca tgcgattata 480
ctgcccttaa ctagtggctg tactttactc gctctctatt ttgtgatcaa gaaactacac 540
ctaaactggc taaaatatgt ggtgaaaatt ttgaatttta atataacact gctaaatatc 600
ccagctggca catttgtcta ctcctacttt ctcaactcac ttttcagaaa cctatcacat 660
ttagcttctt ggaatcccct ggttgtttta ccaaggtatc gtgtaacaat agctgatgat 720
aacgaagacc tgaacaagat aggcgggttt gttaccaatt tgaattacaa agatggattg 780
accaactcag ttgttcacaa gaaaacattg gatgagattg aaaaagatca ttggatgaag 840
catttttaca gaagagaatt agttgaaccg aaggatatta aatcgaagag gcagatcagc 900
aacatgtatt tgaatagcgc attaattgtt tcgttcgttc tgtccatcgt ttctaccgta 960
tatttctatt tatcacccaa tgattggtta atatccaatg ctgtcagtat gaatatggct 1020
atttggtcca ttgctcaatt aaaattgaag aatttaaaat caggggccct aatcctaatt 1080
gctctatttt tttacgacat ttgctttgtc tttggtaccg atgtaatggt tacagtagct 1140
actaaccttg atattcccgt aaaactaagc ttaccagtca agtttaatac agctcaaaac 1200
aacttcaatt tttcaatact tggtctgggt gatattgcct tgcctggtat gtttattgcg 1260
atgtgctaca aatatgacat ctggaagtgg caccttgatc atgatgacac tgaattccac 1320
tttttgaact ggtcatacgt tggaaaatat tttattactg ctatggttag ttacgttgct 1380
tctttggtat ctgccatggt ctccttgtcc attttcaata ctgctcaacc ggctttatta 1490
tacattgttc cttccttgtt gattagtact attttggtag cttgctggaa caaggatttt 1500
aagcagtttt ggaattttca gtatgatacg attgaagtgg ataaaagttt aaaaaaagcg 1560
atagaaaaaa aggagaactc tataacttat tcgaccttca tcctatcaga atactataat 1620
gatgccgaca agtatgcctt gcttggtgat gatgtaaacg aaaattttga cgatgatgaa 1680
gaattcgtgc aagaggaaga tctcagtgac agctctgagg aagagctttc tgaagaagat 1740
ctcttggatg acgaatcttc t 1761
<210> 17
<211> 1560
<212> DNA
<213> Homo sapiens
<900> 17
atggggccgc agcggcggct gtcccctgcc ggggccgccc tactctgggg cttcctgctc 60
cagctgacag ccgctcagga agcaatcttg catgcgtctg gaaatggcac aaccaaggac 120



CA 02360585 2001-07-23
- 17 -
tactgcatgc tttataaccc ttattggaca gctcttccaa gtaccctaga aaatgcaact 180
tccattagtt tgatgaatct gacttccaca ccactatgca acctttctga tattcctcct 240
gttggcataa agagcaaagc agttgtggtt ccatggggaa gctgccattt tcttgaaaaa 300
gccagaattg cacagaaagg aggtgctgaa gcaatgttag ttgtcaataa cagtgtccta 360
tttcctccct caggtaacag atctgaattt cctgatgtga aaatactgat tgcatttata 420
agctacaaag actttagaga tatgaaccag actctaggag ataacattac tgtgaaaatg 480
tattctccat cgtggcctaa ctatgattat actatggtgg gtatttttgg aattgcggtg 540
ttcactgggg cattaagtgg atactggagt ggactagttg aattggaaaa cttgaaagca 600
gtgacaactg aagatagaga aatgaggaaa aagaaggaag aatatttaac ttttagtcct 660
cttacagttg taatatttgt ggtcatctgc tgtgttatga tggtcttact ttatttcttc 720
tacaaatggt tggtttatgt tatgatagca attttctgca tagcatcagc aatgagtctg 780
tacaactgtc ttgctgcact aattcataag ataccatatg gacaatgcac gattgcatgt 840
cgtggcaaaa acatggaagt gagacttatt tttctctctg gactgtgcat agcagtagct 900
gttgtttggg ctgtgtttcg aaatgaagac aggtgggctt ggattttaca ggatatcttg 960
gggattgctt tctgtctgaa tttaattaaa acactgaagt tgcccaactt caagtcatgt 1020
gtgatacttc taggccttct cctcctctat gatgtatttt ttgttttcat aacaccattc 1080
atcacaaaga atggtgagag tatcatggtt gaactcgcag ctggaccttt tggaaataat 1140
gaaaagttgc cagtagtcat cagagtacca aaactgatct atttctcagt aatgagtgtg 1200
!' tgcctcatgc ctgtttcaat attgggtttt ggagacatta ttgtaccagg cctgttgatt 1260
gcatactgta gaagatttga tgttcagact ggttcttctt acatatacta tgtttcgtct 1320
acagttgcct atgctattgg catgatactt acatttgttg ttctggtgct gatgaaaaag 1380
gggcaacctg ctctcctcta tttagtacct tgcacactta ttactgcctc agttgttgcc 1440
tggagacgta aggaaatgaa aaagttctgg aaaggtaaca gctatcagat gatggaccat 1500
ttggattgtg caacaaatga agaaaaccct gtgatatctg gtgaacagat tgtccagcaa 1560
<210> 18
<211> 520
<212> PRT
<213> Homo Sapiens
<400> 18
Met Gly Pro Gln Arg Arg Leu Ser Pro Ala Gly Ala Ala Leu Leu Trp
1 5 10 15
Gly Phe Leu Leu Gln Leu Thr Ala Ala Gln Glu Ala Ile Leu His Ala
20 25 30
Ser Gly Asn Gly Thr Thr Lys Asp Tyr Cys Met Leu Tyr Asn Pro Tyr
35 40 45
Trp Thr Ala Leu Pro Ser Thr Leu Glu Asn Ala Thr Ser Ile Ser Leu
50 55 60
Met Asn Leu Thr Ser Thr Pro Leu Cys Asn Leu Ser Asp Ile Pro Pro
65 70 75 80
Val Gly Ile Lys Ser Lys Ala Val Val Val Pro Trp Gly Ser Cys His
85 90 95
Phe Leu Glu Lys Ala Arg Ile Ala Gln Lys Gly Gly Ala Glu Ala Met
100 105 110
Leu Val Val Asn Asn Ser Val Leu Phe Pro Pro Ser Gly Asn Arg Ser
115 120 125
Glu Phe Pro Asp Val Lys Ile Leu Ile Ala Phe Ile Ser Tyr Lys Asp
130 135 190


CA 02360585 2001-07-23
- 1$ -
Phe Arg Asp Met Asn Gln Thr Leu Gly Asp Asn Ile Thr Val Lys Met
145 150 155 160
Tyr Ser Pro Ser Trp Pro Asn Tyr Asp Tyr Thr Met Val Gly Ile Phe
165 170 175


Gly IleAla ValPheThr GlyAlaLeu SerGlyTyr TrpSerGlyLeu


180 185 190


Val GluLeu GluAsnLeu LysAlaVal ThrThrGlu AspArgGluMet


195 200 205


Arg LysLys LysGluGlu TyrLeuThr PheSerPro LeuThrValVal


210 215 220


Ile PheVal ValIleCys CysValMet MetValLeu LeuTyrPhePhe


225 230 235 240


( Tyr LysTrp LeuValTyr ValMetIle AlaIlePhe CysIleAlaSer


245 250 255


Ala MetSer LeuTyrAsn CysLeuAla AlaLeuIle HisLysIlePro


260 265 27p


Tyr GlyGln CysThrIle AlaCysArg GlyLysAsn MetGluValArg


275 280 285 ,


Leu IlePhe LeuSerGly LeuCysIle AlaValAla ValValTrpAla


290 295 300


Val PheArg AsnGluAsp ArgTrpAla TrpIleLeu GlnAspIleLeu


305 310 315 320


Gly IleAla PheCysLeu AsnLeuIle LysThrLeu LysLeuProAsn


325 330 335


Phe LysSer CysValIle LeuLeuGly LeuLeuLeu LeuTyrAspVal


340 345 350


Phe Phe Val Phe Ile Thr Pro Phe Ile Thr Lys Asn Gly Glu Ser Ile
355 360 365
Met Val Glu Leu Ala Ala Gly Pro Phe Gly Asn Asn Glu Lys Leu Pro
370 375 380
Val Val Ile Arg Val Pro Lys Leu Ile Tyr Phe Ser Val Met Ser Val
385 390 395 400
Cys Leu Met Pro Val Ser Ile Leu Gly Phe Gly Asp Ile Ile Val Pro
405 410 415
Gly Leu Leu Ile Ala Tyr Cys Arg Arg Phe Asp Val Gln Thr Gly Ser
420 425 430
Ser Tyr Ile Tyr Tyr Val Ser Ser Thr Val Ala Tyr Ala Ile Gly Met
435 940 445


' CA 02360585 2001-07-23
- 19 -
IleLeuThr-PheValValLeu ValLeuMet LysLysGly GlnProAla


450 455 460


LeuLeuTyrLeu ValProCys ThrLeuIle ThrAlaSer ValValAla


965 470 475 480


TrpArgArgLys GluMetLys LysPheTrp LysGlyAsn SerTyrGln


985 490 495


MetMetAspHis LeuAspCys AlaThrAsn GluGluAsn ProValIle


500 505 510


SerGlyGluGln IleValGln Gln


515 520


<210> 19
<211> 684
~':.<212> PRT
<213> Homo Sapiens
<400> 19
Met Ala Cys Leu Gly Phe Leu Leu Pro Val Gly Phe Leu Leu Leu Ile
1 5 10 15
Ser Thr Val Ala Gly Gly Lys Tyr Gly Val Ala His Val Val Ser.Glu
20 25 30
Asn Trp Ser Lys Asp Tyr Cys Ile Leu Phe Ser Ser Asp Tyr Ile Thr
35 40 45
Leu Pro Arg Asp Leu His His Ala Pro Leu Leu Pro Leu Tyr Asp Gly
50 55 60
Thr Lys Ala Pro Trp Cys Pro Gly Glu Asp Ser Pro His Gln Ala Gln
65 70 75 80
Leu Arg Ser Pro Ser Gln Arg Pro Leu Arg Gln Thr Thr Ala Met Val
C. ~ 85 90 95
Met Arg Gly Asn Cys Ser Phe His Thr Lys Gly Trp Leu Ala Gln Gly
100 105 110
Gln Gly Ala His Gly Leu Leu Ile Val Ser Arg Val Ser Asp Gln Gln
115 120 125
Cys Ser Asp Thr Thr Leu Ala Pro Gln Asp Pro Arg Gln Pro Leu Ala
130 135 140
Asp Leu Thr Ile Pro Val Ala Met Leu His Tyr Ala Asp Met Leu Asp
145 150 155 160
Ile Leu Ser His Thr Arg Gly Glu Ala Val Val Arg Val Ala Met Tyr
165 170 175
Ala Pro Pro Glu Pro Ile Ile Asp Tyr Asn Met Leu Val Ile Phe Ile
180 185 190



CA 02360585 2001-07-23
- 20 -
Leu Ala Val Gly Thr Val Ala Ala Gly Gly Tyr Trp Ala Gly Leu Thr
195 200 205
Glu Ala Asn Arg Leu Gln Arg Arg Arg Ala Arg Arg Gly Gly Gly Ser
210 215 220
Gly Gly His His Gln Leu Gln Glu Ala Ala Ala Ala Glu Gly Ala Gln
225 230 235 240
Lys Glu Asp Asn Glu Asp Ile Pro Val Asp Phe Thr Pro Ala Met Thr
245 250 255
Gly Val Val Val Thr Leu Ser Cys Ser Leu Met Leu Leu Leu Tyr Phe
260 265 270
Phe Tyr Asp His Phe Val Tyr Val Thr Ile Gly Ile Phe Gly Leu Gly
275 280 285
Ala Gly Ile Gly Leu Tyr Ser Cys Leu Ser Pro Leu Val Cys His Leu
290 295 300
Ser Leu Arg Gln Tyr Gln Arg Pro Pro His Ser Leu Trp Ala Ser Leu
305 310 315 320
Pro Leu Pro Leu Leu Leu Leu Ala Ser Leu Cys Ala Thr Val Lle Ile
325 330 335,
Phe Trp Val Ala Tyr Arg Asn Glu Asp Arg Trp Ala Trp Leu Leu Gln
340 395 350
Asp Thr Leu Gly Ile Ser Tyr Cys Leu Phe Val Leu His Arg Val Arg
355 360 365
Leu Pro Thr Leu Lys Asn Cys Ser Ser Phe Leu Leu Ala Leu Leu Ala
370 375 380
Phe Asp Val Phe Phe Val Phe Val Thr Pro Phe Phe Thr Lys Thr Gly
385 390 395 400
w
Glu Ser Ile Met Ala Gln Val Ala Leu Gly Pro Ala Glu Ser Ser Ser
405 410 415
His Glu Arg Leu Pro Met Val Leu Lys Val Pro Arg Leu Arg Val Ser
420 425 430
Ala Leu Thr Leu Cys Ser Gln Pro Phe Ser Ile Leu Gly Phe Gly Asp
435 440 445
Ile Val Val Pro Gly Phe Leu Val Ala Tyr Cys Cys Arg Phe Asp Val
450 455 460
Gln Val Cys Ser Arg Gln.Ile Tyr Phe Val Ala Cys Thr Val Ala Tyr
965 970 475 480
Ala Val Gly Leu Leu Val Thr Phe Met Ala Met Val Leu Met Gln Met
485 490 495



CA 02360585 2001-07-23
- 21 -
GlyGlnPro AlaLeuLeu TyrLeuValSer SerThrLeu LeuThr Ser


500 505 510


LeuAlaVal AlaAlaCys ArgGlnGluLeu SerLeuPhe TrpThr Gly


515 520 525


GlnGlyArg AlaLysMet CysGlyLeuGly CysAlaPro SerAla Gly


530 535 540


SerArgGln LysGlnGlu GlyAlaAlaAsp AlaHisThr AlaSer Thr


545 550 555 560


LeuGluArg GlyThrSer ArgGlyAlaGly AspLeuAsp SerAsn Pro


565 570 575


GlyGluAsp ThrThrGlu IleValThrIle SerGluAsn GluAla Thr


580 585 590


t~, . Asn Pro Glu Asp Arg Ser Asp Ser Ser Glu Gly Trp Ser Asp Ala His
595 600 605
Leu Asp Pro Asn Glu Leu Pro Phe Ile Pro Pro Gly Ala Ser Glu Glu
610 615 620
Leu Met Pro Leu Met Pro Met Ala Met Leu Ile Pro Leu Met Pro Leu
625 630 635 640
Met Pro Pro Pro Ser Glu Leu Gly His Val His Ala Gln Ala Gln Ala
645 650 655
His Glu Thr Gly Leu Pro Trp Ala Gly Leu His Lys Arg Lys Gly Leu
660 665 670
Lys Val Arg Lys Ser Met Ser Thr Gln Ala Pro Leu
675 680
<210> 20
<211> 2052
<212> DNA
<213> Homo sapiens
<400> 20
atggcgtgcc tgggcttcct cctccccgtg ggcttcctcc tcctcatcag caccgtggcc 60
gggggaaagt acggcgtggc ccacgtggtg tcggagaatt ggagcaagga ctactgtatc 120
ctgttcagct ccgactacat caccctcccc cgggacctgc accacgcccc actcctgccc 180
ctgtatgatg gcaccaaggc accctggtgc ccgggtgagg attcccccca ccaggcccag 240
ctccgctccc ccagccagcg gcccctccgc cagaccactg ccatggtcat gaggggtaac 300
tgcagcttcc acacgaaagg ctggctggct cagggccaag gtgcccacgg gctgctcatc 360
gtgagccggg tcagtgacca acagtgctca gacaccaccc tggcacccca ggatccccgc 420
cagcccctgg cagacctcac catccctgtg gctatgctcc actatgctga catgctggac 480
atcctcagcc acactcgtgg ggaggccgtc gtccgcgtgg ccatgtacgc acccccagag 540
cccatcatcg actacaacat gctggtcatc ttcatcctgg ctgtgggcac agtggctgca 600
ggcggctact gggccggcct gaccgaagcc aaccggctac agcggcgccg tgcccgaaga 660
ggaggggggt ctggtggtca ccatcagctg caggaagctg cagcagctga gggagcccag 720
aaggaagata atgaggacat cccagtggac ttcacgccgg ccatgacagg cgtggtggtc 780
accctgtcct gctcgctcat gctgctgctc tacttcttct atgaccactt tgtctatgtc 840
accattggga tctttggcct gggtgctggc attggcctct acagctgcct gtcacccctg 900



~' ~ CA 02360585 2001-07-23
- 22 -
gtgtgccacc tgtccctgcg gcaataccag aggcctccgc acagcctctg ggcctctctg 960
ccgctgcctc tgctgctgct ggcgagcctg tgcgcaaccg tgatcatctt ctgggtggcc 1020
taccgcaatg aggaccgctg ggcgtggctc ctgcaggaca cactgggcat ttcctactgc 1080
ctgttcgtcc tgcaccgtgt gcggctgccc actctcaaga actgctcctc cttcctgctg 1140
gccctgctgg cctttgatgt cttctttgtc ttcgtcaccc ccttcttcac caaaaccggt 1200
gagagcatca tggcgcaggt tgccttgggc cctgcagagt cttcaagcca tgagaggctg 1260
cccatggtac tcaaagtgcc ccggctaaga gtctccgcct tgaccctgtg cagccagccc 1320
ttctccatcc ttggcttcgg tgacattgtg gtccccggct tcctggttgc ttactgttgc 1380
cgctttgatg tgcaagtctg ctcccgtcag atctacttcg tggcctgcac cgtggcctat 1440
gctgtgggcc tgctggtcac attcatggcc atggtcctca tgcagatggg ccaacctgcc 1500
ttgctctacc tagtgtccag caccctgctc accagcctgg ctgtggctgc ctgccgccaa 1560
gagctcagcc tcttctggac tggccagggc agagctaaga tgtgtgggct cggctgtgcc 1620
ccttcggctg gctctaggca gaagcaggag ggcgcagcag atgcccacac agccagcaca 1680
cttgagagag gcaccagccg aggagcaggg gacttagaca gcaaccctgg agaagacacc 1740
actgagattg tcaccatatc tgagaatgaa gccaccaatc cagaggaccg cagtgatagc 1800
tccgagggct ggagtgacgc ccacttggat cctaatgagc tgcccttcat cccccctggg 1860
gcctcggagg agctgatgcc actgatgcca atggccatgc tgatcccact catgcccctg 1920
atgcccccgc cctcagagct gggccatgtc catgcccagg cccaggccca cgagactggc 1980
~'''\' ctgccctggg cgggactcca caagaggaag ggtttgaaag taagaaagag catgtcgacc 2040
caggctccct tg 2052



CA 02360585 2001-07-23
LEDIGLICH ZUR INFORMATION
Codes zur Identifizierung von PCT-Vertragsstaaten auf den Kopfbogen der
Schriften, die intelnationale Anmeldungen gemass dem
PCT veroffentlichen.
ALAlbanien ES Spanien LS Lesotho SI Slowenien


AMAnnenien FI Finnland LT Litauen SK Slowakei


ATOsterreich FR Frankreich LU Luxemburg SN Senegal


AUAustralien GA Gabun LV Lettland SZ Swasiland


AZAserbaidschan GB Vereinigtes MC Monaco TD Tschad
K6nigreich


BABosnien-HerzegowinaGE Georgien MD Republik MoldauTG Togo


BBBarbados GH Ghana MG Madagaskar TJ Tadschikistan


BEBelgien GN Guinea MK Die ehemaligeTM Turkmenistan
jugoslawische


BFBurkina Faso GR Griechenland Republik MazedonienTR Tiirkei


BGBulgarien HU Ungarn ML Mali TT Trinidad
and Tobago


BJBenin IE Trland MN Mongolei UA Ukraine


BRBrasilien IL Israel MR Mauretanien UG Uganda


BYBelarus IS Island MW Malawi US Vereinigte
Staaten
von


CAKanada IT Italien MX Mexiko Amerika


CFZentralafrikanischeJP Japan NE Niger UZ Usbekistan
Republik


CGKongo KE Kenia NL Niederlande VN Vietnam


CHSchweiz KG Kirgisistan NO Norwegen YU Jugoslawien


CIC8te d'Ivoire KP Demokratische NZ Neuseeland ZW Zimbabwe
Volksrepublik


CMKamerun Korea PL Polen


CNChina KR Republik KoreaPT Portugal


CUKuba KZ Kasachstan RO Rum~nien


CZTschechische LC St. Lucia RU Russische
Republik Ftideration


DEDeutschland LI Liechtenstein SD Sudan


DKDanemark LK Sri Lanka SE Schweden


EEEstland LR Liberia SG Singapur





CA 02360585 2001-07-23
WO 00/43505 PCT/EP00/00390
1
SEQUENZPROTOKOLL
<110> Memorec Stoffel GmbH
<120> Protease
<130> Protease Memorec
<140>
<141>
<150> 19902550.9
<151> 1999-O1-22
<150> 19925946.1
<151> 1999-06-08
<150> 19929115.2
<151> 1999-06-29
<160> 20
<170> PatentIn Ver. 2.1
<210> 1
<211> 592
<212> PRT
<213> Homo sapiens
<400> 1
Met Ala Ala Ala Val Ala Ala Ala Leu Ala Arg Leu Leu Ala Ala Phe
1 5 10 15
Leu Leu Leu Ala Ala Gln Val Ala Cys Glu Tyr Gly Met Val His Val
20 25 30
Val Ser Gln Ala Gly Gly Pro Glu Gly Lys Asp Tyr Cys Ile Leu Tyr
35 40 45
Asn Pro Gln Trp Ala His Leu Pro His Asp Leu Ser Lys Ala Ser Phe
50 55 60
Leu Gln Leu Arg Asn Trp Thr Ala Ser Leu Leu Cys Ser Ala Ala Asp
65 70 75 80
Leu Pro Ala Arg Gly Phe Ser Asn Gln Ile Pro Leu Val Ala Arg Gly
85 90 95
Asn Cys Thr Phe Tyr Glu Lys Val Arg Leu Ala Gln Gly Ser Gly Ala
100 105 110
Arg Gly Leu Leu Ile Val Ser Arg Glu Arg Leu Val Pro Pro Gly Gly
115 120 125
Asn Lys Thr Gln Tyr Asp Glu Ile Gly Ile Pro Val Ala Leu Leu Ser
130 135 140



CA 02360585 2001-07-23
WO 00/43505 PCT/EP00/00390
- 2 -
Tyr Asp
Lys Met
Leu
Asp
Ile
Phe
Thr
Arg
Phe
Gly
Arg
Thr
Val
Arg


145 150 155 160


Ala Leu Glu Val
Ala Tyr Pro
Ala Val
Pro Leu
Lys Asp
Tyr
Asn
Met


165 170 175


IleIle PheIleMet Ala Gly Ala Ile Trp
Val Thr Gly
Val Gly
Tyr


180 185 190


AlaGly SerArgAsp ValLysLys Arg LysHisLys ArgAsp
Tyr
Met


195 200 205


AspGly ProGluLys GlnGluAsp GluAlaVal AspValThr ProVal


210 215 220


MetThr CysValPhe ValValMet CysCysSer MetLeuVal LeuLeu


225 230 235 240


TyrTyr PheTyrAsp LeuLeuVal TyrValVal IleGlyIle PheCys


295 250 255


LeuAla SerAlaThr GlyLeuTyr SerCysLeu AlaProCys ValArg


260 265 270


ArgLeu ProPheGly LysCysArg IleProAsn AsnSerLeu ProTyr


275 280 285


PheHis LysArgPro GlnAlaArg MetLeuLeu LeuAlaLeu PheCys


290 295 300


ValAla ValSerVal ValTrpGly ValPheArg AsnGluAsp GlnTrp


305 310 315 320


AlaTrp ValLeuGln AspAlaLeu GlyIleAla PheCysLeu TyrMet


325 330 335


LeuLys ThrIleArg LeuProThr PheLysAla CysThrLeu LeuLeu


340 345 350


LeuVal LeuPheLeu TyrAspIle PhePheVal PheIleThr ProPhe


355 360 365


LeuThr LysSerGly SerSerIle MetValGlu ValAlaThr GlyPro


370 375 380


SerAsp SerAlaThr ArgGluLys LeuProMet ValLeuLys ValPro


385 390 395 400


ArgLeu SerSer ProLeu LeuCysAsp ArgProPhe Ser
Asn Ala Leu


405 410 415


LeuGly PheGlyAsp IleLeu ProGlyLeu LeuVal Tyr
Val Ala Cys


420 425 430


His Ile GlnVal SerSerArg Tyr
Arg Gln Val Phe
Phe Val
Asp Ala


435 440 445





CA 02360585 2001-07-23
WO 00/43505 PCT/EP00/00390
- 3 -
Cys ThrIleAla TyrGlyVal GlyLeuLeu ValThrPhe ValAlaLeu


450 455 460


Ala LeuMetGln ArgGlyGln ProAlaLeu LeuTyrLeu ValProCys


465 470 475 480


Thr LeuValThr SerCysAla ValAlaLeu TrpArgArg GluLeuGly


485 490 495


Val PheTrpThr GlySerGly PheAlaLys ValLeuPro ProSerPro


500 505 510


Trp AlaProAla ProAlaAsp GlyProGln ProProLys AspSerAla


515 520 525


Thr ProLeuSer ProGlnPro ProSerGlu GluProAla ThrSerPro


530 535 540


Trp ProAlaGlu GlnSerPro LysSerArg ThrSerGlu GluMetGly


545 550 555 560


Ala GlyAlaPro MetArgGlu ProGlySer ProAlaGlu SerGluGly


565 570 575


Arg AspGlnAla GlnProSer ProValThr GlnProGly AlaSerAla


580 585 590


<210> 2
<211> 520
<212> PRT
<213> Homo sapiens
<400> 2
Met Gly Pro Gln Arg Arg Leu Ser Pro Ala Gly Ala Ala Leu Leu Trp
1 5 10 15
Gly Phe Leu Leu Gln Leu Thr Ala Ala Gln Glu Ala Ile Leu His Ala
20 25 30
Ser Gly Asn Gly Thr Thr Lys Asp Tyr Cys Met Leu Tyr Asn Pro Tyr
35 40 45
Trp Thr Ala Leu Pro Ser Thr Leu Glu Asn Ala Thr Ser Ile Ser Leu
50 55 60
Met Asn Leu Thr Ser Thr Pro Leu Cys Asn Leu Ser Asp Ile Pro Pro
65 70 75 80
Val Gly Ile Lys Ser Lys Ala Val Val Val Pro Trp Gly Ser Cys His
85 90 95
Phe Leu Glu Lys Ala Arg Ile Ala Gln Lys Gly Gly Ala Glu Ala Met
100 105 110
Leu Val Val Asn Asn Ser Val Leu Phe Pro Pro Ser Gly Asn Arg Ser
115 120 125



CA 02360585 2001-07-23
WO 00/43505 PCT/EP00/00390
- 4 -
Glu Pro
Phe Asp
Val
Lys
Ile
Leu
Ile
Ala
Phe
Ile
Ser
Tyr
Lys
Asp


130 135 190


Phe Asp Asn Leu
Arg Met Gln Gly
Thr Asp
Asn
Ile
Thr
Val
Lys
Met


145 150 155 160


Tyr SerPro TrpPro PheAsp Val
Ser Asn Tyr Ile
Thr Phe
Met
Val


165 170 175


Val IleAlaVal PheThrVal AlaLeu Trp
Gly Ser
Gly Gly
Tyr Leu


180 185 190


Val GluLeuGlu AsnLeuLys AlaValThr Asp Met
Thr Arg
Glu Glu


195 200 205


Arg LysLysLys GluGluTyr LeuThrPhe ProLeu Thr Val
Ser Val


210 215 220


Ile PheValVal IleCysCys ValMetMet LeuLeu Tyr Phe
Val Phe


225 230 235 240


Tyr LysTrpLeu ValTyrVal MetIleAla PheCys Ile Ser
Ile Ala


245 250 255


Ala MetSerLeu TyrAsnCys LeuAlaAla IleHis Lys Pro
Leu Ile


260 265 270


Tyr GlyGlnCys ThrIleAla CysArgGly AsnMet Glu Arg
Lys Val


275 280 285


Leu IlePheLeu SerGlyLeu CysIleAla AlaVal Val Ala
Val Trp


290 295 300


Val PheArgAsn GluAspArg TrpAlaTrp LeuGln Asp Leu
Ile Ile


305 310 315 320


Gly IleAlaPhe CysLeuAsn LeuIleLys LeuLys Leu Asn
Thr Pro


325 330 335


Phe LysSerCys ValIleLeu LeuGlyLeu LeuLeu Tyr Val
Leu Asp


340 345 350


Phe PheValPhe IleThrPro PheIleThr AsnGly Glu Ile
Lys Ser


355 360 365


Met ValGluLeu AlaAlaGly ProPheGly AsnGlu Lys Pro
Asn Leu


370 375 380


Val ValIleArg ValProLys LeuIleTyr SerVal Met Val
Phe Ser


385 390 395 400


Cys Leu Pro ValSerIle GlyPhe AspIle Ile Pro
Met Leu Gly Val


405 410 415


Gly Leu Ile TyrCys Phe ValGln Thr Ser
Leu Ala Arg Asp Gly
Arg


420 425 430





CA 02360585 2001-07-23
WO 00/43505 PCT/EP00/00390
- 5 -
Ser Tyr Ile Tyr Tyr Val Ser Ser Thr Val Ala Tyr Ala Ile Gly Met
435 440 445
Ile Leu Thr Phe Val Val Leu Val Leu Met Lys Lys Gly Gln Pro Ala
450 455 460
Leu Leu Tyr Leu Val Pro Cys Thr Leu Ile Thr Ala Ser Val Val Ala
465 470 475 480
Trp Arg Arg Lys Glu Met Lys Lys Phe Trp Lys Gly Asn Ser Tyr Gln
485 490 495
Met Met Asp His Leu Asp Cys Ala Thr Asn Glu Glu Asn Pro Val Ile
500 505 510
Ser Gly Glu Gln Ile Val Gln Gln
515 520
<210> 3
<211> 377
<212> PRT
<213> Homo sapiens
<400> 3
Met Asp Ser Ala Leu Ser Asp Pro His Asn Gly Ser Ala Glu Ala Gly
1 5 10 15
Gly Pro Thr Asn Ser Thr Thr Arg Pro Pro Ser Thr Pro Glu Gly Ile
20 25 30
Ala Leu Ala Tyr Gly Ser Leu Leu Leu Met Ala Leu Leu Pro Ile Phe
35 40 45
Phe Gly Ala Leu Arg Ser Val Arg Cys Ala Arg Gly Lys Asn Ala Ser
50 55 60
Asp Met Pro Glu Thr Ile Thr Ser Arg Asp Ala Ala Arg Phe Pro Ile
65 70 75 80
Ile Ala Ser Cys Thr Leu Leu Gly Leu Tyr Leu Phe Phe Lys Ile Phe
85 90 95
Ser Gln Glu Tyr Ile Asn Leu Leu Leu Ser Met Tyr Phe Phe Val Leu
100 105 110
Gly Ile Leu Ala Leu Ser His Thr Ile Ser Pro Phe Met Asn Lys Phe
115 120 125
Phe Pro Ala Ser Phe Pro Asn Arg Gln Tyr Gln Leu Leu Phe Thr Gln
130 135 140
Gly Ser Gly Glu Asn Lys Glu Glu Ile Ile Asn Tyr Glu Phe Asp Thr
145 150 155 160
Lys Asp Leu Val Cys Leu Gly Leu Ser Ser Ile Val Gly Val Trp Tyr
165 170 175



CA 02360585 2001-07-23
WO 00/43505 PCT/EP00/00390
- 6 -
LeuLeuArg LysHisTrp IleAla AsnAsnLeu PheGlyLeu AlaPhe


180 185 190


SerLeuAsn GlyValGlu LeuLeu HisLeuAsn AsnValSer ThrGly


195 200 205


CysIleLeu LeuGlyGly LeuPhe IleTyrAsp ValPheTrp ValPhe


210 215 220


GlyThrAsn ValMetVal ThrVal AlaLysSer PheGluAla ProIle


225 230 235 240


LysLeuVal PheProGln AspLeu LeuGluLys GlyLeuGlu AlaAsn


245 250 255


AsnPheAla MetLeuGly LeuGly AspValVal IleProGly IlePhe


260 265 270


IleAlaLeu LeuLeuArg PheAsp IleSerLeu LysLysAsn ThrHis


275 280 285


ThrTyrPhe TyrThrSer PheAla AlaTyrIle PheGlyLeu GlyLeu


290 295 300


ThrIlePhe IleMetHis IlePhe LysHisAla GlnProAla LeuLeu


305 310 315 320


TyrLeuVal ProAlaCys IleGly PheProVal LeuValAla LeuAla


325 330 335


LysGlyGlu ValThrGlu MetPhe SerTyrGlu GluSerAsn ProLys


340 345 350


AspProAla AlaValThr GluSer LysGluGly ThrGluAla SerAla


355 360 365


SerLysGly LeuGluLys LysGlu Lys


370 375


<210>
4


<211>
384


<212>
PRT


<213> Sapiens
Homo


<400>
4


Met Ala Gln ThrTyr SerTrpAla Tyr Leu ValAspSer Ser
Glu Ser


1 5 10 15


Gln Val Thr PheLeu IleSerIle Leu Ile ValTyrGly Ser
Ser Leu


20 25 30


Phe Arg Leu AsnMet AspPheGlu Asn Asp LysGluLys Asp
Ser Gln


35 40 45


Ser Asn Ser SerGly SerPheAsn Gly Ser ThrAsnAsn Ser
Ser Asn


50 55 60





CA 02360585 2001-07-23
WO 00/43505 PCT/EP00/00390
Ile Gln Thr Ile Asp Ser Thr Gln Ala Leu Phe Leu Pro Ile Gly Ala
65 70 75 80
Ser Val Ser Leu Leu Val Met Phe Phe Phe Phe Asp Ser Val Gln Val
85 90 95
Val Phe Thr Ile Cys Thr Ala Val Leu Ala Thr Ile Ala Phe Ala Phe
100 105 110
Leu Leu Leu Pro Met Cys Gln Tyr Leu Thr Arg Pro Cys Ser Pro Gln
115 120 125
Asn Lys Ile Ser Phe Gly Cys Cys Gly Arg Phe Thr Ala Ala Glu Leu
130 135 140
Leu Ser Phe Ser Leu Ser Val Met Leu Val Leu Ile Trp Val Leu Thr
145 150 155 160
Gly His Trp Leu Leu Met Asp Ala Leu Ala Met Gly Leu Cys Val Ala
165 170 175
Met Ile Ala Phe Val Arg Leu Pro Ser Leu Lys Val Ser Cys Leu Leu
180 185 190
Leu Ser Gly Leu Leu Ile Tyr Asp Val Phe Trp Val Phe Phe Ser Ala
195 200 205
Tyr Ile Phe Asn Ser Asn Val Met Val Lys Val Ala Thr Gln Pro Ala
210 215 220
Asp Asn Pro Leu Asp Val Leu Ser Arg Lys Leu His Leu Gly Pro Asn
225 230 235 240
Val Gly Arg Asp Val Pro Arg Leu Ser Leu Pro Gly Lys Leu Val Phe
245 250 255
Pro Ser Ser Thr Gly Ser His Phe Ser Met Leu Gly Ile Gly Asp Ile
260 265 270
Val Met Pro Gly Leu Leu Leu Cys Phe Val Leu Arg Tyr Asp Asn Tyr
275 280 285
Lys Lys Gln Ala Ser Gly Asp Ser Cys Gly Ala Pro Gly Pro Ala Asn
290 295 300
Ile Ser Gly Arg Met Gln Lys Val Ser Tyr Phe His Cys Thr Leu Ile
305 310 315 320
Gly Tyr Phe Val Gly Leu Leu Thr Ala Thr Val Ala Ser Arg Ile His
325 330 335
Arg Ala Ala Gln Pro Ala Leu Leu Tyr Leu Val Pro Phe Thr Leu Leu
340 345 350
Pro Leu Leu Thr Met Ala Tyr Leu Lys Gly Asp Leu Arg Arg Met Trp
355 360 365



CA 02360585 2001-07-23
WO 00/43505 PCT/EP00/00390
_ g _
Ser Glu Pro Phe His Ser Lys Ser Ser Ser Ser Arg Phe Leu Glu Val
370 375 380
<210>



<211> 13
1


<212> RT
P


<213> us lus
M muscu


<400>
5


Val GlyPhe GlyAspIle IleVal ProGlyLeu LeuIleAla Tyr
Leu


1 5 10 15


Cys ArgPhe AspValGln ThrGly SerSerIle TyrTyrIle Ser
Arg


20 25 30


Ser IleAla TyrAlaVal GlyMet IleIleThr PheValVal Leu
Thr


35 40 45


Met MetLys ThrGlyGln ProAla LeuLeuTyr LeuValPro Cys
Val


50 55 60


Thr IleThr ValSerVal ValAla TrpSerArg LysGluMet Lys
Leu


65 70 75 80


Lys TrpLys GlySerSer TyrGln ValMetAsp HisLeuAsp Tyr
Phe


85 90 95


Ser AsnGlu GluAsnPro ValThr ThrAspGlu GlnIleVal Gln
Thr


100 105 110


Gln


<210>
6


<211>
378


<212>
PRT


<213> usculus
Mus m


<400>
6


Met Asp Ala ValSerAsp ProHisAsn GlySerAla GluAlaGly
Ser


1 5 10 15


Thr Pro Asn GlyThrThr ArgProPro SerThrPro GluGlyIle
Ala


20 25 30


Ala Leu Tyr GlySerLeu LeuLeuMet AlaLeuLeu ProIlePhe
Ala


35 40 45


Phe Gly Leu ProSerVal ArgCysAla ArgGlyLys SerSerSer
Ala


50 55 60


Asp Met Glu ThrIleThr SerArgAsp AlaAlaArg PheProIle
Pro


65 70 75 80


Ile Ala Cys ThrLeuLeu GlyLeuTyr LeuPhePhe LysIlePhe
Ser


85 90 95





CA 02360585 2001-07-23
WO 00/43505 PCT/EP00/00390
- 9 _
Ser Gln Glu Tyr Ile Asn Leu Leu Leu Ser Met Tyr Phe Phe Val Leu
100 105 110
Gly Ile Leu Ala Leu Ser His Thr Ile Ser Pro Phe Met Asn Lys Phe
115 120 125
Phe Pro Ala Asn Phe Pro Asn Arg Gln Tyr Gln Leu Leu Phe Thr Gln
130 135 140
Gly Ser Gly Glu Asn Lys Glu Glu Ile Ile Asn Tyr Glu Phe Asp Thr
145 150 155 160
Lys Asp Leu Val Cys Leu Gly Leu Ser Ser Val Val Gly Val Trp Tyr
165 170 175
Leu Leu Arg Lys His Trp Ile Ala Asn Asn Leu Phe Gly Leu Ala Phe
180 185 190
Ser Leu Asn Gly Val Glu Leu Leu His Leu Asn Asn Val Ser Thr Gly
195 200 205
Cys Ile Leu Leu Gly Gly Leu Phe Ile Tyr Asp Ile Phe Trp Val Phe
210 215 220
Gly Thr Asn Val Met Val Thr Val Ala Lys Ser Phe Glu Ala Pro Ile
225 230 235 240
Lys Leu Val Phe Pro Gln Asp Leu Leu Glu Lys Gly Leu Glu Ala Asp
245 250 255
Asn Phe Ala Met Leu Gly Leu Gly Asp Ile Val Ile Pro Gly Ile Phe
260 265 270
Ile Ala Leu Leu Leu Arg Phe Asp Ile Ser Leu Lys Lys Asn Thr His
275 280 285
Thr Tyr Phe Tyr Thr Ser Phe Ala Ala Tyr Ile Phe Gly Leu Gly Leu
290 295 300
Thr Ile Phe Ile Met His Ile Phe Lys His Ala Gln Pro Ala Leu Leu
305 310 315 320
Tyr Leu Val Pro Ala Cys Ile Gly Phe Pro Val Leu Val Ala Leu Ala
325 330 335
Lys Gly Glu Val Ala Glu Met Phe Ser Tyr Glu Glu Ser Asn Pro Lys
340 345 350
Asp Pro Ala Ala Val Thr Glu Ser Lys Glu Glu Ser Thr Glu Ala Ser
355 360 365
Ala Ser Lys Arg Leu Glu Lys Lys Glu Lys
370 375
<210> 7
<211> 257
<212> PRT
<213> Mus musculus



CA 02360585 2001-07-23
WO 00/43505 PCT/EP00/00390
- 10 -
<400> 7
Gln Asn Lys Ile Ser Phe Gly Cys Cys Gly Arg Phe Thr Ala Ala Glu
1 5 10 15
Leu Leu Ser Phe Tyr Leu Ser Val Met Leu Val Leu Ile Trp Val Leu
20 25 30
Thr Gly His Trp Leu Leu Met Asp Ala Leu Ala Met Gly Leu Cys Val
35 40 45
Ala Met Ile Ala Phe Val Arg Leu Pro Ser Leu Lys Val Ser Cys Leu
50 55 60
Leu Leu Ser Gly Leu Leu Ile Tyr Asp Val Phe Trp Val Phe Phe Ser
65 70 75 80
Ala Tyr Ile Phe Asn Ser Asn Val Met Val Lys Val Ala Thr Gln Pro
85 90 95
A1a Asp Asn Pro Leu Asp Val Leu Ser Arg Lys Leu His Leu Gly Pro
100 105 110
Asn Val Gly Arg Asp Val Pro Arg Leu Ser Leu Pro Gly Lys Leu Val
115 120 125
Phe Pro Ser Ser Thr Gly Ser His Phe Ser Met Leu Gly Ile Gly Asp
130 135 140
Ile Val Met Pro Gly Leu Leu Leu Cys Phe Val Leu Arg Tyr Asp Asn
145 150 155 160
Tyr Lys Lys Gln Ala Ser Gly Asp Ser Cys Gly Ala Pro Gly Xaa Ala
165 170 175
Asn Ile Ser Gly Arg Met Gln Lys Val Ser Tyr Phe His Cys Thr Leu
180 185 190
Ile Gly Tyr Phe Val Gly Leu Leu Thr Ala Thr Val Ala Ser Arg Val
195 200 205
His Arg Ala Ala Gln Pro Ala Leu Leu Tyr Leu Val Pro Phe Thr Leu
210 215 220
Leu Pro Leu Leu Thr Met Ala Tyr Leu Lys Gly Asp Leu Arg Arg Met
225 230 235 240
Trp Ser Glu Pro Phe His Ser Lys Ser Ser Ser Ser Arg Phe Leu Glu
245 250 255
Val
<210> 8
<211> 587
<212> PRT
<213> Saccharomyces cerevisiae



CA 02360585 2001-07-23
WO 00/43505 PCT/EP00/00390
- 11 -
<400> 8
Met Asp Lys Tyr Leu Asn Ser Phe Val Asp His Leu Ser Glu Trp Ser
1 5 10 15
Ser Arg Ala Phe Arg Asn Asn Ser Ser Ser Ala Asn Gln Ser Ala Ser
20 25 30
Asn Lys Glu Leu Glu Gln Val Phe Glu Gln Ile Asn Ala Ile Val Glu
35 40 45
Asn His Asn Asn Lys Leu Thr Thr Ala Phe Asp Lys Ile Ser Tyr Arg
50 55 60
Val Ala His Lys Ile Thr His Leu Val Glu Ser His Ser Leu Val Phe
65 70 75 80
Asn Tyr Ala Thr Leu Val Leu Ile Ala Ser Ala Leu Val Val Ile Gly
85 90 95
Ser Phe Thr Ser Ile Ser Ser Ile Pro Phe Thr Ala Leu Pro Pro Thr
100 105 110
Arg Glu His Ser Leu Phe Asp Pro Thr Asp Phe Asp Val Asp His Asp
115 120 125
Cys His Val Ile Tyr Arg Glu Asn Asp Glu Asp Lys Lys Lys Lys Lys
130 135 140
Lys Ser Lys Arg Phe Phe Asp Met Met Asp Glu Lys His Ala Ile Ile
145 150 155 160
Leu Pro Leu Thr Ser Gly Cys Thr Leu Leu Ala Leu Tyr Phe Val Ile
165 170 175
Lys Lys Leu His Leu Asn Trp Leu Lys Tyr Val Val Lys Ile Leu Asn
180 185 190
Phe Asn Ile Thr Leu Leu Asn Ile Pro Ala Gly Thr Phe Val Tyr Ser
195 200 205
Tyr Phe Leu Asn Ser Leu Phe Arg Asn Leu Ser His Leu Ala Ser Trp
210 215 220
Asn Pro Leu Val Val Leu Pro Arg Tyr Arg Val Thr Ile Ala Asp Asp
225 230 235 240
Asn Glu Asp Leu Asn Lys Ile Gly Gly Phe Val Thr Asn Leu Asn Tyr
245 250 255
Lys Asp Gly Leu Thr Asn Ser Val Val His Lys Lys Thr Leu Asp Glu
260 265 270
Ile Glu Lys Asp His Trp Met Lys His Phe Tyr Arg Arg Glu Leu Val
275 280 285
Glu Pro Lys Asp Ile Lys Ser Lys Arg Gln Ile Ser Asn Met Tyr Leu
290 295 300



CA 02360585 2001-07-23
WO 00/43505 PCT/EP00/00390
- 12 -
Asn
Ser
Ala
Leu
Ile
Val
Ser
Phe
Val
Leu
Ser
Ile
Val
Ser
Thr
Val


305 310 315 320


Tyr Ser Asp Trp
Phe Pro Leu
Tyr Asn Ile
Leu Ser
Asn
Ala
Val
Ser


325 330 335


Met MetAlaIle Trp Ala LeuLys
Asn Ser Gln Asn
Ile Leu Leu
Lys


340 345 350


Lys Gly Leu Ile Ile Ala Phe TyrAsp Cys
Ser Ala Leu Leu Phe Ile


355 360 365


Phe PheGlyThr Asp Met ValThrValAla ThrAsn Asp
Val Val Leu


370 375 380


Ile ValLysLeu Ser Pro ValLysPheAsn ThrAla Asn
Pro Leu Gln


385 390 , 395 400


Asn AsnPheSer Ile Gly LeuGlyAspIle AlaLeu Gly
Phe Leu Pro


405 410 415


Met IleAlaMet Cys Lys TyrAspIleTrp LysTrp Leu
Phe Tyr His


420 425 430


Asp AspAspThr Glu His PheLeuAsnTrp SerTyr Gly
His Phe Val


435 440 445


Lys PheIleThr Ala Val SerTyrValAla SerLeu Ser
Tyr Met Val


450 455 460


Ala ValSerLeu Ser Phe AsnThrAlaGln ProAla Leu
Met Ile Leu


465 470 475 480


Tyr ValProSer Leu Ile SerThrIleLeu ValAla Trp
Ile Leu Cys


485 490 495


Asn AspPheLys Gln Trp AsnPheGlnTyr AspThr Glu
Lys Phe Ile


500 505 510


Val LysSerLeu Lys Ala IleGluLysLys GluAsn Ile
Asp Lys Ser


515 520 525


Thr SerThrPhe Ile Ser GluTyrTyrAsn Asp Lys
Tyr Leu Ala
Asp


530 535 540


Tyr LeuLeuGly Val GluAsnPhe Asp Glu
Ala Asp Asn Asp
Asp Asp


545 550 555 560


Glu ValGln Leu AspSerSer Glu Leu
Phe Glu Ser Glu
Glu Glu
Asp


565 570 575


Ser GluAsp SerSer
Glu Leu
Leu
Asp
Asp
Glu


580 585


<210>
9


<211> 76
17


<212>
DNA





CA 02360585 2001-07-23
WO 00/43505 PCT/EP00/00390
- 13 -
<213> Saccharomyces cerevisiae
<400> 9
atggcggcag cggtggcggc tgcgctggcg cggcttttgg cggcctttct gctcctcgcg 60
gcccaggtgg cctgtgagta cggcatggtg cacgtggtct cccaggccgg gggccccgaa 120
ggcaaagact actgcatcct ctacaacccg cagtgggccc atcttccgca cgacctcagc 180
aaggcatctt tcctgcagct gcgcaactgg acggcctccc tgctctgctc cgcagccgac 240
ctccccgccc gtggcttcag caaccagatc ccgctggtgg cgcgggggaa ctgcaccttc 300
tatgagaaag tgaggctggc ccagggcagc ggagcacgcg ggctgctcat cgtcagcagg 360
gagaggctgg tccccccggg gggtaataag acgcagtatg atgagattgg cattcccgtg 420
gccctgctca gctacaaaga catgctggac atcttcacgc gtttcggccg cacggtgagg 480
gcggcgctgt atgcgcctaa ggagccggtg ctggactaca acatggtcat catcttcatc 540
atggctgtgg gcaccgtcgc catcggcggc tactgggccg ggagtcggga cgtgaagaaa 600
aggtacatga agcacaagcg cgacgatggg cccgagaagc aggaggacga ggcggtggac 660
gtgacgccgg tgatgacctg cgtgtttgtg gtgatgtgct gctccatgct ggtgctgctc 720
tactacttct acgacctcct cgtgtacgtg gtcatcggga tcttctgcct ggcctccgcc 780
accggcctct acagctgcct ggcgccctgt gtgcggcggc tgcccttcgg caagtgcagg 840
atccccaaca acagcctgcc ctacttccac aagcgcccgc aggcccgtat gctgctcctg 900
gcgctcttct gcgtggccgt cagcgtggtg tggggcgtct tccgcaacga ggaccagtgg 960
gcctgggtcc tccaggatgc cctgggcatc gccttctgcc tctacatgct gaagaccatc 1020
cgtctgccca ccttcaaggc ctgcacgctg ctgctgctgg tgctgttcct ctacgacatc 1080
ttcttcgtgt tcatcacgcc cttcctgacc aagagtggga gcagcatcat ggtggaggtg 1140
gccactgggc cctcggactc agccacccgt gagaagctgc ccatggtcct gaaggtgccc 1200
aggctgaact cctcacctct ggccctgtgt gaccggccct tctccctcct gggtttcgga 1260
gacattttgg tgccagggct gctggtggcc tactgccaca ggtttgacat ccaggtacag 1320
tcctccaggg tatacttcgt ggcctgcacc atcgcctatg gcgttggcct ccttgtgaca 1380
ttcgtggcac tggccctgat gcagcgtggc cagcccgctc tcctctacct ggtgccctgc 1440
acgctggtga cgagctgcgc tgtggcgctc tggcgccggg agctgggcgt gttctggacg 1500
ggcagcggct ttgcgaaagt cctacctcca tctccgtggg ccccagcacc agccgacggc 1560
ccgcagcctc ccaaagactc tgccacgcca ctctccccgc agccgcccag cgaagaacca 1620
gccacatccc cctggcctgc tgagcagtcc ccaaaatcac gcacgtccga ggagatgggg 1680
gctggagccc ccatgcggga gcctgggagc ccagctgaat ccgagggccg ggaccaggcc 1740
cagccgtccc cggtaaccca gcctggcgcc tcggcc 1776
<210> 10
<211> 1560
<212> DNA
<213> Homo Sapiens
<400> 10
atggggccgc agcggcggct gtcccctgcc ggggccgccc tactctgggg cttcctgctc 60
cagctgacag ccgctcagga agcaatcttg catgcgtctg gaaatggcac aaccaaggac 120
tactgcatgc tttataaccc ttattggaca gctcttccaa gtaccctaga aaatgcaact 180
tccattagtt tgatgaatct gacttccaca ccactatgca acctttctga tattcctcct 240
gttggcataa agagcaaagc agttgtggtt ccatggggaa gctgccattt tcttgaaaaa 300
gccagaattg cacagaaagg aggtgctgaa gcaatgttag ttgtcaataa cagtgtccta 360
tttcctccct caggtaacag atctgaattt cctgatgtga aaatactgat tgcatttata 420
agctacaaag actttagaga tatgaaccag actctaggag ataacattac tgtgaaaatg 480
tattctccat cgtggcctaa ctttgattat actatggtgg ttatttttgt aattgcggtg 540
ttcactgtgg cattaggtgg atactggagt ggactagttg aattggaaaa cttgaaagca 600
gtgacaactg aagatagaga aatgaggaaa aagaaggaag aatatttaac ttttagtcct 660
cttacagttg taatatttgt ggtcatctgc tgtgttatga tggtcttact ttatttcttc 720
tacaaatggt tggtttatgt tatgatagca attttctgca tagcatcagc aatgagtctg 780
tacaactgtc ttgctgcact aattcataag ataccatatg gacaatgcac gattgcatgt 840
cgtggcaaaa acatggaagt gagacttatt tttctctctg gactgtgcat agcagtagct 900
gttgtttggg ctgtgtttcg aaatgaagac aggtgggctt ggattttaca ggatatcttg 960
gggattgctt tctgtctgaa tttaattaaa acactgaagt tgcccaactt caagtcatgt 1020



CA 02360585 2001-07-23
WO 00/43505 PCT/EP00/00390
- 14 -
gtgatacttc taggccttct cctcctctat gatgtatttt ttgttttcat aacaccattc 1080
atcacaaaga atggtgagag tatcatggtt gaactcgcag ctggaccttt tggaaataat 1140
gaaaagttgc cagtagtcat cagagtacca aaactgatct atttctcagt aatgagtgtg 1200
tgcctcatgc ctgtttcaat attgggtttt ggagacatta ttgtaccagg cctgttgatt 1260
gcatactgta gaagatttga tgttcagact ggttcttctt acatatacta tgtttcgtct 1320
acagttgcct atgctattgg catgatactt acatttgttg ttctggtgct gatgaaaaag 1380
gggcaacctg ctctcctcta tttagtacct tgcacactta ttactgcctc agttgttgcc 1440
tggagacgta aggaaatgaa aaagttctgg aaaggtaaca gctatcagat gatggaccat 1500
ttggattgtg caacaaatga agaaaaccct gtgatatctg gtgaacagat tgtccagcaa 1560
<210> 11
<211> 1131
<212> DNA
<213> Homo Sapiens
<400> 11
atggactcgg ccctcagcga tccgcataac ggcagtgccg aggcaggcgg ccccaccaac 60
agcactacgc ggccgccttc cacgcccgag ggcatcgcgc tggcctacgg cagcctcctg 120
ctcatggcgc tgctgcccat cttcttcggc gccctgcgct ccgtacgctg cgcccgcggc 180
aagaatgctt cagacatgcc tgaaacaatc.accagccggg atgccgcccg cttccccatc 240
atcgccagct gcacactctt ggggctctac ctctttttca aaatattctc ccaggagtac 300
atcaacctcc tgctgtccat gtatttcttc gtgctgggaa tcctggccct gtcccacacc 360
atcagcccct tcatgaataa gttttttcca gccagctttc caaatcgaca gtaccagctg 420
ctcttcacac agggttctgg ggaaaacaag gaagagatca tcaattatga atttgacacc 480
aaggacctgg tgtgcctggg cctgagcagc atcgttggcg tctggtacct gctgaggaag 540
cactggattg ccaacaacct ttttggcctg gccttctccc ttaatggagt agagctcctg 600
cacctcaaca atgtcagcac tggctgcatc ctgctgggcg gactcttcat ctacgatgtc 660
ttctgggtat ttggcaccaa tgtgatggtg acagtggcca agtccttcga ggcaccaata 720
aaattggtgt ttccccagga tctgctggag aaaggcctcg aagcaaacaa ctttgccatg 780
ctgggacttg gagatgtcgt cattccaggg atcttcattg ccttgctgct gcgctttgac 840
atcagcttga agaagaatac ccacacctac ttctacacca gctttgcagc ctacatcttc 900
ggcctgggcc ttaccatctt catcatgcac atcttcaagc atgctcagcc tgccctccta 960
tacctggtcc ccgcctgcat cggttttcct gtcctggtgg cgctggccaa gggagaagtg 1020
acagagatgt tcagttatga ggagtcaaat cctaaggatc cagcggcagt gacagaatcc 1080
aaagagggaa cagaggcatc agcatcgaag gggctggaga agaaagagaa a 1131
<210> 12
<211> 1152
<212> DNA
<213> Homo sapiens
<400> 12
atggcggagc agacctactc gtgggcctat tccctggtgg attccagtca agtgtctaca 60
tttctgattt ccattcttct tatagtctat ggtagtttca ggtcccttaa tatggacttt 120
gaaaatcaag ataaggagaa agacagtaat agttcttctg ggtctttcaa tggcaacagc 180
accaataata gcatccaaac aattgactct acccaggctc tgttccttcc aattggagca 240
tctgtctctc ttttagtaat gttcttcttc tttgactcag ttcaagtagt ttttacaata 300
tgtacagcag ttcttgcaac gatagctttt gcttttcttc tcctcccgat gtgccagtat 360
ttaacaagac cctgctcacc tcagaacaag atttcctttg gttgctgtgg acgtttcact 420
gctgctgagt tgctgtcatt ctctctgtct gtcatgctcg tcctcatctg ggttctcact 480
ggccattggc ttctcatgga tgcactggcc atgggcctct gtgtcgccat gatcgccttt 540
gtccgcctgc cgagcctcaa ggtctcctgc ctgcttctct cagggcttct catctatgat 600
gtcttttggg tatttttctc agcctacatc ttcaatagca acgtcatggt gaaggtggcc 660
actcagccgg ctgacaatcc ccttgacgtt ctatcccgga agctccacct ggggcccaat 720
gttgggcgtg atgttcctcg cctgtctctg cctggaaaac tggtcttccc aagctccact 780
ggcagccact tctccatgtt gggcatcgga gacatcgtta tgcctggtct cctactatgc 840



CA 02360585 2001-07-23
WO 00/43505 PCT/EP00/00390
- 15 -
tttgtccttc gctatgacaa ctacaaaaag caagccagtg gggactcctg tggggcccct 900
ggacctgcca acatctccgg gcgcatgcag aaggtctcct actttcactg caccctcatc 960
ggatactttg taggcctgct cactgctact gtggcgtctc gcattcaccg ggccgcccag 1020
cccgcccttc tctatttggt gccatttact ttattgccac tcctcacgat ggcctattta 1080
aagggcgacc tccggcggat gtggtctgag cctttccact ccaagtccag cagctcccga 1140
ttcctggaag to 1152
<210> 13
<211> 339
<212> DNA
<213> Mus musculus
<400> 13
gtattgggtt tcggagatat cattgtacca ggcctgttga ttgcatattg tagaagattc 60
gatgttcaga ctggttcttc tatatactat atttcatcca caattgccta tgctgttggc 120
atgatcatta cctttgttgt cctgatggtg atgaaaacag ggcagcctgc tctcctctac 180
ttggtacctt gtacacttat tactgtctca gtcgttgctt ggagtcgtaa ggaaatgaaa 240
aagttctgga aaggcagcag ctatcaggtg atggaccacc tggactattc aacaaatgaa 300
gaaaatccag tgacgactga tgagcagatt gtacaacag 339
<210> 14
<211> 1134
<212> DNA
<213> Mus musculus
<400> 14
atggattcgg ctgtcagcga tccgcacaac ggcagcgccg aggctggcac cccagccaac 60
ggcacgacgc ggccgccctc cacgcccgag ggcatcgcgc tggcctacgg cagcctcctg 120
ctcatggcgc tgctgcccat cttcttcggc gccctgccgt cggtgcgctg cgcccgcggc 180
aagagctctt cggacatgcc agaaaccatc accagtcgag atgccgcccg cttccccatc 240
atcgccagct gcacactcct ggggctctac ctctttttca aaatattctc ccaggagtac 300
atcaacctct tgctgtccat gtatttcttc gtgctgggga tcctggccct gtcacacacc 360
atcagcccct tcatgaataa gttttttcca gccaacttcc caaaccgcca gtatcagctg 420
ctcttcacac agggctctgg ggaaaacaaa gaagagatca tcaactatga gtttgacact 480
aaggacctgg tgtgcctggg cctaagcagc gtcgttggtg tctggtacct tctgaggaag 540
cactggattg ccaacaacct gtttggcctg gccttctccc ttaatggggt agagctcctg 600
cacctgaaca acgtgagcac tggctgtatc ctgctcggag gactcttcat ctatgacatc 660
ttctgggtat tcggcaccaa cgtgatggtg acagtggcca agtcctttga ggcaccaata 720
aaattggtgt tcccccagga tctgctggag aagggccttg aagcagacaa ctttgccatg 780
ctgggacttg gagacattgt cattccaggg atcttcattg c~ttactgct tcgttttgac 840
atcagcttga agaagaacac gcacacctac ttctacacca gcttcgccgc ctacatcttc 900
ggcctgggtc tcaccatctt catcatgcac atcttcaagc acgcccagcc ggctctcctg 960
tacctggtcc ctgcctgcat cggctttcct gtcctggtgg cactagccaa gggagaagtg 1020
gccgagatgt tcagttatga ggagtccaac cctaaagatc cagcagccgt gactgaatcc 1080
aaagaggagt caacagaggc gtcggcatcg aagaggctag agaagaagga gaaa 1134
<210> 15
<211> 771
<212> DNA
<213> Mus musculus
<400> 15
cagaacaaga tttccttcgg ttgctgtggg cgtttcactg ctgccgagct gctgtcgttc 60
tacctgtctg tcatgctcgt cctcatctgg gttctcactg gccactggct tctcatggat 120
gctctggcca tgggtctctg tgttgccatg atcgccttcg tccgcctgcc aagcctcaag 180



CA 02360585 2001-07-23
WO 00/43505 PCT/EP00/00390
- 16 -
gtttcctgcc tgcttctctc agggcttctc atctacgatg tcttctgggt gttcttctca 240
gcctacatct tcaacagtaa tgtcatggtg aaagtggcca cacagccagc tgacaatccc 300
ctcgacgttc tgtccaggaa gctccacctg ggacccaatg tggggcgtga tgttcctcgc 360
ctgtctttgc ctggaaaatt ggtcttccca agctccactg gcagtcactt ctctatgctg 420
ggcatcgggg acattgtgat gcccggcctc ctgttatgct ttgttcttcg ctatgacaac 480
tacaagaaac aagccagtgg tgactcgtgt ggggcccctg gcanngccaa tatctctggg 590
cgcatgcaga aggtctccta cttccactgc accctcatcg ggtactttgt aggtctgctc 600
actgcgactg tggcgtctcg cgtccaccga gctgcccagc cagctctcct ctacttggtg 660
ccatttaccc tattgccact cctcaccatg gcctacctaa agggtgactt acggaggatg 720
tggtctgagc ccttccactc caagtccagc agctcccggt tcctggaagt a 771
<210> 16
<211> 1761
<212> DNA
<213> Saccharomyces cerevisiae
<400> 16
atggacaagt atttgaattc atttgttgac cacctttcag agtggtcatc tcgtgccttt 60
aggaacaatt catcaagcgc taaccaaagt gcgtcgaaca aggaattaga acaagttttt 120
gaacagatca atgctatagt tgaaaaccac aataacaaat taaccactgc ctttgataag 180
atatcatatc gcgttgctca caagattaca cacttggtgg aaagccattc tttagtattc 240
aactacgcca ctttagttct catcgcaagt gctttggtcg ttattggctc atttacgtct 300
atttcttcta ttccatttac agctctacct cctacgagag aacactcatt gtttgatcct 360
acagattttg atgtggacca cgactgtcat gttatctacc gcgagaatga cgaagataaa 420
aagaaaaaga agaaaagcaa gaggtttttc gatatgatgg atgaaaaaca tgcgattata 480
ctgcccttaa ctagtggctg tactttactc gctctctatt ttgtgatcaa gaaactacac 540
ctaaactggc taaaatatgt ggtgaaaatt ttgaatttta atataacact gctaaatatc 600
ccagctggca catttgtcta ctcctacttt ctcaactcac ttttcagaaa cctatcacat 660
ttagcttctt ggaatcccct ggttgtttta ccaaggtatc gtgtaacaat agctgatgat 720
aacgaagacc tgaacaagat aggcgggttt gttaccaatt tgaattacaa agatggattg 780
accaactcag ttgttcacaa gaaaacattg gatgagattg aaaaagatca ttggatgaag 840
catttttaca gaagagaatt agttgaaccg aaggatatta aatcgaagag gcagatcagc 900
aacatgtatt tgaatagcgc attaattgtt tcgttcgttc tgtccatcgt ttctaccgta 960
tatttctatt tatcacccaa tgattggtta atatccaatg ctgtcagtat gaatatggct 1020
atttggtcca ttgctcaatt aaaattgaag aatttaaaat caggggccct aatcctaatt 1080
gctctatttt tttacgacat ttgctttgtc tttggtaccg atgtaatggt tacagtagct 1140
actaaccttg atattcccgt aaaactaagc ttaccagtca agtttaatac agctcaaaac 1200
aacttcaatt tttcaatact tggtctgggt gatattgcct tgcctggtat gtttattgcg 1260
atgtgctaca aatatgacat ctggaagtgg caccttgatc atgatgacac tgaattccac 1320
tttttgaact ggtcatacgt tggaaaatat tttattactg ctatggttag ttacgttgct 1380
tctttggtat ctgccatggt ctccttgtcc attttcaata ctgctcaacc ggctttatta 1440
tacattgttc cttccttgtt gattagtact attttggtag cttgctggaa caaggatttt 1500
aagcagtttt ggaattttca gtatgatacg attgaagtgg ataaaagttt aaaaaaagcg 1560
atagaaaaaa aggagaactc tataacttat tcgaccttca tcctatcaga atactataat 1620
gatgccgaca agtatgcctt gcttggtgat gatgtaaacg aaaattttga cgatgatgaa 1680
gaattcgtgc aagaggaaga tctcagtgac agctctgagg aagagctttc tgaagaagat 1740
ctcttggatg acgaatcttc t 1761
<210> 17
<211> 1560
<212> DNA
<213> Homo Sapiens
<400> 17
atggggccgc agcggcggct gtcccctgcc ggggccgccc tactctgggg cttcctgctc 60
cagctgacag ccgctcagga agcaatcttg catgcgtctg gaaatggcac aaccaaggac 120



CA 02360585 2001-07-23
WO 00/43505 PCT/EP00/00390
- 17 -
tactgcatgc tttataaccc ttattggaca gctcttccaa gtaccctaga aaatgcaact 180
tccattagtt tgatgaatct gacttccaca ccactatgca acctttctga tattcctcct 240
gttggcataa agagcaaagc agttgtggtt ccatggggaa gctgccattt tcttgaaaaa 300
gccagaattg cacagaaagg aggtgctgaa gcaatgttag ttgtcaataa cagtgtccta 360
tttcctccct caggtaacag atctgaattt cctgatgtga aaatactgat tgcatttata 420
agctacaaag actttagaga tatgaaccag actctaggag ataacattac tgtgaaaatg 480
tattctccat cgtggcctaa ctatgattat actatggtgg gtatttttgg aattgcggtg 540
ttcactgggg cattaagtgg atactggagt ggactagttg aattggaaaa cttgaaagca 600
gtgacaactg aagatagaga aatgaggaaa aagaaggaag aatatttaac ttttagtcct 660
cttacagttg taatatttgt ggtcatctgc tgtgttatga tggtcttact ttatttcttc 720
tacaaatggt tggtttatgt tatgatagca attttctgca tagcatcagc aatgagtctg 780
tacaactgtc ttgctgcact aattcataag ataccatatg gacaatgcac gattgcatgt 840
cgtggcaaaa acatggaagt gagacttatt tttctctctg gactgtgcat agcagtagct 900
gttgtttggg ctgtgtttcg aaatgaagac aggtgggctt ggattttaca ggatatcttg 960
gggattgctt tctgtctgaa tttaattaaa acactgaagt tgcccaactt caagtcatgt 1020
gtgatacttc taggccttct cctcctctat gatgtatttt ttgttttcat aacaccattc 1080
atcacaaaga atggtgagag tatcatggtt gaactcgcag ctggaccttt tggaaataat 1140
gaaaagttgc cagtagtcat cagagtacca aaactgatct atttctcagt aatgagtgtg 1200
tgcctcatgc ctgtttcaat attgggtttt ggagacatta ttgtaccagg cctgttgatt 1260
gcatactgta gaagatttga tgttcagact ggttcttctt acatatacta tgtttcgtct 1320
acagttgcct atgctattgg catgatactt acatttgttg ttctggtgct gatgaaaaag 1380
gggcaacctg ctctcctcta tttagtacct tgcacactta ttactgcctc agttgttgcc 1440
tggagacgta aggaaatgaa aaagttctgg aaaggtaaca gctatcagat gatggaccat 1500
ttggattgtg caacaaatga agaaaaccct gtgatatctg gtgaacagat tgtccagcaa 1560
<210> 18
<211> 520
<212> PRT
<213> Homo sapiens
<400> 18
Met Gly Pro Gln Arg Arg Leu Ser Pro Ala Gly Ala Ala Leu Leu Trp
1 5 10 15
Gly Phe Leu Leu Gln Leu Thr Ala Ala Gln Glu Ala Ile Leu His Ala
20 25 30
Ser Gly Asn Gly Thr Thr Lys Asp Tyr Cys Met Leu Tyr Asn Pro Tyr
35 40 45
Trp Thr Ala Leu Pro Ser Thr Leu Glu Asn Ala Thr Ser Ile Ser Leu
50 55 60
Met Asn Leu Thr Ser Thr Pro Leu Cys Asn Leu Ser Asp Ile Pro Pro
65 70 75 80
Val Gly Ile Lys Ser Lys Ala Val Val Val Pro Trp Gly Ser Cys His
85 90 95
Phe Leu Glu Lys Ala Arg Ile Ala Gln Lys Gly Gly Ala Glu Ala Met
100 105 110
Leu Val Val Asn Asn Ser Val Leu Phe Pro Pro Ser Gly Asn Arg Ser
115 120 125
Glu Phe Pro Asp Val Lys Ile Leu Ile Ala Phe Ile Ser Tyr Lys Asp
130 135 140



CA 02360585 2001-07-23
WO 00/43505 PCT/EP00/00390
- 18 -
Phe Arg Asp Met Asn Gln Thr Leu Gly Asp Asn Ile Thr Val Lys Met
145 150 155 160
Tyr Ser Pro Ser Trp Pro Asn Tyr Asp Tyr Thr Met Val Gly Ile Phe
165 170 175
Gly Ile Ala Val Phe Thr Gly Ala Leu Ser Gly Tyr Trp Ser Gly Leu
180 185 190
Val Glu Leu Glu Asn Leu Lys Ala Val Thr Thr Glu Asp Arg Glu Met
195 200 205
Arg Lys Lys Lys Glu Glu Tyr Leu Thr Phe Ser Pro Leu Thr Val Val
210 215 220
Ile Phe Val Val Ile Cys Cys Val Met Met Val Leu Leu Tyr Phe Phe
225 230 235 240
Tyr Lys Trp Leu Val Tyr Val Met Ile Ala Ile Phe Cys Ile Ala Ser
245 250 255
Ala Met Ser Leu Tyr Asn Cys Leu Ala Ala Leu Ile His Lys Ile Pro
260 265 270
Tyr Gly Gln Cys Thr Ile Ala Cys Arg Gly Lys Asn Met Glu Val Arg
275 280 285
Leu Ile Phe Leu Ser Gly Leu Cys Ile Ala Val Ala Val Val Trp Ala
290 295 300
Val Phe Arg Asn Glu Asp Arg Trp Ala Trp Ile Leu Gln Asp Ile Leu
305 310 315 320
Gly Ile Ala Phe Cys Leu Asn Leu Ile Lys Thr Leu Lys Leu Pro Asn
325 330 335
Phe Lys Ser Cys Val Ile Leu Leu Gly Leu Leu Leu Leu Tyr Asp Val
340 345 350
Phe Phe Val Phe Ile Thr Pro Phe Ile Thr Lys Asn Gly Glu Ser Ile
355 360 365
Met Val Glu Leu Ala Ala Gly Pro Phe Gly Asn Asn Glu Lys Leu Pro
370 375 380
Val Val Ile Arg Val Pro Lys Leu Ile Tyr Phe Ser Val Met Ser Val
385 390 395 400
Cys Leu Met Pro Val Ser Ile Leu Gly Phe Gly Asp Ile Ile Val Pro
405 410 415
Gly Leu Leu Ile Ala Tyr Cys Arg Arg Phe Asp Val Gln Thr Gly Ser
420 425 430
Ser Tyr Ile Tyr Tyr Val Ser Ser Thr Val Ala Tyr Ala Ile Gly Met
435 440 445



CA 02360585 2001-07-23
WO 00/43505 PCT/EP00/00390
- 19 -
Ile Leu Thr Phe Val Val Leu Val Leu Met Lys Lys Gly Gln Pro Ala
450 455 460
Leu Leu Tyr Leu Val Pro Cys Thr Leu Ile Thr Ala Ser Val Val Ala
465 470 475 480
Trp Arg Arg Lys Glu Met Lys Lys Phe Trp Lys Gly Asn Ser Tyr Gln
485 490 495
Met Met Asp His Leu Asp Cys Ala Thr Asn Glu Glu Asn Pro Val Ile
500 505 510
Ser Gly Glu Gln Ile Val Gln Gln
515 520
<210>
19


<211> 684


<212> PRT


<213> Homosapiens


<400> 19


MetAla LeuGlyPhe LeuLeuPro ValGlyPhe LeuLeu LeuIle
Cys


1 5 10 15


SerThr AlaGlyGly LysTyrGly ValAlaHis ValVal SerGlu
Val


20 25 30


AsnTrp LysAspTyr CysIleLeu PheSerSer AspTyr IleThr
Ser


35 40 45


LeuPro AspLeuHis HisAlaPro LeuLeuPro LeuTyr AspGly
Arg


50 55 60


ThrLys ProTrpCys ProGlyGlu AspSerPro HisGln AlaGln
Ala


65 70 75 80


LeuArg ProSerGln ArgProLeu ArgGlnThr ThrAla MetVal
Ser


85 90 95


MetArg AsnCysSer PheHisThr LysGlyTrp LeuAla GlnGly
Gly


100 105 110


GlnGly HisGlyLeu LeuIleVal SerArgVal SerAsp GlnGln
Ala


115 120 125


CysSer ThrThrLeu AlaProGln AspProArg GlnPro LeuAla
Asp


130 135 140


AspLeu IleProVal AlaMetLeu HisTyrAla AspMet LeuAsp
Thr


145 150 155 160


IleLeu HisThrArg GlyGluAla ValValArg ValAla MetTyr
Ser


165 170 175


AlaPro GluProIle IleAspTyr AsnMetLeu ValIle PheIle
Pro


180 185 190





CA 02360585 2001-07-23
WO 00/43505 PCT/EP00/00390
- 20 -
Leu ValGly Ala Gly Ala
Ala Thr Gly Gly
Val Tyr Leu
Ala Trp Thr


195 200 205


Glu AsnArgLeu Gln Arg Arg Arg Gly Ser
Ala Arg Ala Arg Gly
Gly


210 215 220


GlyGly HisHisGln LeuGlnGlu AlaAlaAla AlaGluGly Gln
Ala


225 230 235 240


LysGlu AspAsnG1u AspIlePro ValAspPhe ThrProAla MetThr


245 250 255


GlyVal ValValThr LeuSerCys SerLeuMet LeuLeuLeu TyrPhe


260 265 270


PheTyr AspHisPhe ValTyrVal ThrIleGly IlePheGly LeuGly


275 280 285


AlaGly IleGlyLeu TyrSerCys LeuSerPro LeuValCys HisLeu


290 295 300


SerLeu ArgGlnTyr GlnArgPro ProHisSer LeuTrpAla SerLeu


305 310 315 320


ProLeu ProLeuLeu LeuLeuAla SerLeuCys AlaThrVal IleIle


325 330 335


PheTrp ValAlaTyr ArgAsnGlu AspArgTrp AlaTrpLeu LeuGln


340 345 350


AspThr LeuGlyIle SerTyrCys LeuPheVal LeuHisArg ValArg


355 360 365


LeuPro ThrLeuLys AsnCysSer SerPheLeu LeuAlaLeu LeuAla


370 375 380


PheAsp ValPhePhe ValPheVal ThrProPhe PheThrLys ThrGly


385 390 395 400


GluSer IleMetAla GlnValAla LeuGlyPro AlaGluSer SerSer


405 410 415


HisGlu ArgLeuPro MetValLeu LysValPro ArgLeuArg ValSer


420 425 430


AlaLeu ThrLeuCys SerGlnPro PheSerIle LeuGlyPhe GlyAsp


435 440 445


IleVal ValProGly PheLeuVal TyrCys CysArgPhe AspVal
Ala


450 455 460


GlnVal CysSerArg GlnIleTyr ValAla CysThrVal AlaTyr
Phe


465 470 475 480


AlaVal LeuLeu ValThrPhe Ala Val Met Gln
Gly Met Met Leu Met


485 490 495





CA 02360585 2001-07-23
WO 00/43505 PCT/EP00/00390
- 21 -
Gly Gln Pro Ala Leu Leu Tyr Leu Val Ser Ser Thr Leu Leu Thr Ser
500 505 510
Leu Ala Val Ala Ala Cys Arg Gln Glu Leu Ser Leu Phe Trp Thr Gly
515 520 525
Gln Gly Arg Ala Lys Met Cys Gly Leu Gly Cys Ala Pro Ser Ala Gly
530 535 540
Ser Arg Gln Lys Gln Glu Gly Ala Ala Asp Ala His Thr Ala Ser Thr
545 550 555 560
Leu Glu Arg Gly Thr Ser Arg Gly Ala Gly Asp Leu Asp Ser Asn Pro
565 570 575
Gly Glu Asp Thr Thr Glu Ile Val Thr Ile Ser Glu Asn Glu Ala Thr
580 585 590
Asn Pro Glu Asp Arg Ser Asp Ser Ser Glu Gly Trp Ser Asp Ala His
595 600 605
Leu Asp Pro Asn Glu Leu Pro Phe Ile Pro Pro Gly Ala Ser Glu Glu
610 615 620
Leu Met Pro Leu Met Pro Met Ala Met Leu Ile Pro Leu Met Pro Leu
625 630 635 640
Met Pro Pro Pro Ser Glu Leu Gly His Val His Ala Gln Ala Gln Ala
645 650 655
His Glu Thr Gly Leu Pro Trp Ala Gly Leu His Lys Arg Lys Gly Leu
660 665 670
Lys Val Arg Lys Ser Met Ser Thr Gln Ala Pro Leu
675 680
<210> 20
<211> 2052
<212> DNA
<213> Homo Sapiens
<400> 20
atggcgtgcc tgggcttcct cctccccgtg ggcttcctcc tcctcatcag caccgtggcc 60
gggggaaagt acggcgtggc ccacgtggtg tcggagaatt ggagcaagga ctactgtatc 120
ctgttcagct ccgactacat caccctcccc cgggacctgc accacgcccc actcctgccc 180
ctgtatgatg gcaccaaggc accctggtgc ccgggtgagg attcccccca ccaggcccag 240
ctccgctccc ccagccagcg gcccctccgc cagaccactg ccatggtcat gaggggtaac 300
tgcagcttcc acacgaaagg ctggctggct cagggccaag gtgcccacgg gctgctcatc 360
gtgagccggg tcagtgacca acagtgctca gacaccaccc tggcacccca ggatccccgc 420
cagcccctgg cagacctcac catccctgtg gctatgctcc actatgctga catgctggac 480
atcctcagcc acactcgtgg ggaggccgtc gtccgcgtgg ccatgtacgc acccccagag 540
cccatcatcg actacaacat gctggtcatc ttcatcctgg ctgtgggcac agtggctgca 600
ggcggctact gggccggcct gaccgaagcc aaccggctac agcggcgccg tgcccgaaga 660
ggaggggggt ctggtggtca ccatcagctg caggaagctg cagcagctga gggagcccag 720
aaggaagata atgaggacat cccagtggac ttcacgccgg ccatgacagg cgtggtggtc 780
accctgtcct gctcgctcat gctgctgctc tacttcttct atgaccactt tgtctatgtc 840
accattggga tctttggcct gggtgctggc attggcctct acagctgcct gtcacccctg 900



CA 02360585 2001-07-23
WO 00/43505 PCT/EP00/00390
- 22 -
gtgtgccacc tgtccctgcg gcaataccag aggcctccgc acagcctctg ggcctctctg 960
ccgctgcctc tgctgctgct ggcgagcctg tgcgcaaccg tgatcatctt ctgggtggcc 1020
taccgcaatg aggaccgctg ggcgtggctc ctgcaggaca cactgggcat ttcctactgc 1080
ctgttcgtcc tgcaccgtgt gcggctgccc actctcaaga actgctcctc cttcctgctg 1140
gccctgctgg cctttgatgt cttctttgtc ttcgtcaccc ccttcttcac caaaaccggt 1200
gagagcatca tggcgcaggt tgccttgggc cctgcagagt cttcaagcca tgagaggctg 1260
cccatggtac tcaaagtgcc ccggctaaga gtctccgcct tgaccctgtg cagccagccc 1320
ttctccatcc ttggcttcgg tgacattgtg gtccccggct tcctggttgc ttactgttgc 1380
cgctttgatg tgcaagtctg ctcccgtcag atctacttcg tggcctgcac cgtggcctat 1440
gctgtgggcc tgctggtcac attcatggcc atggtcctca tgcagatggg ccaacctgcc 1500
ttgctctacc tagtgtccag caccctgctc accagcctgg ctgtggctgc ctgccgccaa 1560
gagctcagcc tcttctggac tggccagggc agagctaaga tgtgtgggct cggctgtgcc 1620
ccttcggctg gctctaggca gaagcaggag ggcgcagcag atgcccacac agccagcaca 1680
cttgagagag gcaccagccg aggagcaggg gacttagaca gcaaccctgg agaagacacc 1740
actgagattg tcaccatatc tgagaatgaa gccaccaatc cagaggaccg cagtgatagc 1800
tccgagggct ggagtgacgc ccacttggat cctaatgagc tgcccttcat cccccctggg 1860
gcctcggagg agctgatgcc actgatgcca atggccatgc tgatcccact catgcccctg 1920
atgcccccgc cctcagagct gggccatgtc catgcccagg cccaggccca cgagactggc 1980
ctgccctggg cgggactcca caagaggaag ggtttgaaag taagaaagag catgtcgacc 2040
caggctccct tg 2052

Representative Drawing

Sorry, the representative drawing for patent document number 2360585 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date Unavailable
(86) PCT Filing Date 2000-01-19
(87) PCT Publication Date 2000-07-27
(85) National Entry 2001-07-23
Dead Application 2006-01-19

Abandonment History

Abandonment Date Reason Reinstatement Date
2004-01-19 FAILURE TO PAY APPLICATION MAINTENANCE FEE 2004-06-29
2005-01-19 FAILURE TO REQUEST EXAMINATION
2005-01-19 FAILURE TO PAY APPLICATION MAINTENANCE FEE

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $300.00 2001-07-23
Maintenance Fee - Application - New Act 2 2002-01-21 $100.00 2001-07-23
Registration of a document - section 124 $100.00 2002-02-20
Registration of a document - section 124 $100.00 2002-08-27
Maintenance Fee - Application - New Act 3 2003-01-20 $100.00 2002-12-17
Reinstatement: Failure to Pay Application Maintenance Fees $200.00 2004-06-29
Maintenance Fee - Application - New Act 4 2004-01-19 $100.00 2004-06-29
Registration of a document - section 124 $100.00 2004-09-29
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
MEMOREC BIOTEC GMBH
Past Owners on Record
HOFMANN, KAY
MEMOREC MEDICAL MOLECULAR RESEARCH COLOGNE STOFFEL GMBH
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Description 2001-07-23 50 2,042
Description 2001-12-21 28 1,132
Abstract 2001-07-23 1 13
Claims 2001-07-23 2 66
Cover Page 2001-12-11 1 30
PCT 2001-07-23 15 731
Assignment 2001-07-23 4 151
Correspondence 2001-11-26 1 31
Assignment 2001-11-21 1 32
Correspondence 2001-12-18 1 31
Prosecution-Amendment 2001-12-21 26 971
Correspondence 2002-02-20 4 157
Assignment 2002-02-20 4 168
Correspondence 2002-04-04 1 13
Assignment 2002-08-27 3 123
Correspondence 2002-10-31 1 12
Fees 2004-06-29 1 36
Assignment 2004-09-29 3 76

Biological Sequence Listings

Choose a BSL submission then click the "Download BSL" button to download the file.

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.

Please note that files with extensions .pep and .seq that were created by CIPO as working files might be incomplete and are not to be considered official communication.

BSL Files

To view selected files, please enter reCAPTCHA code :